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THE PROPERDIN SYSTEM IN HOST RESISTANCE 
INTRODUCTION 
The ability of a host to resist infection can be broadly 
ascribed to humoral and cellular factors active against the 
invading organismso Phagocytosis is one process by which the 
host is able to limit and destroy foreign matter introduced 
into the bodyo At present there is an abundance of informa-
tion concerning the ingestion process and effects of various 
compounds on the phagocytic ability of phagocytes o In con-
trast, there is much less information concerning the fate of 
the ingested matter {cytopepsis)o The lack of information 
concerning cytopeptic activity of phagocytes may be due 
primarily to unsuitable techniques for quantitating the di-
gestion process o 
The rate of ingestion of particulate matter by phagocytes 
has been shown to be increased in the presence of thermostable 
opsonin and thermolabile complemente Furthermore, properdin 
(Pillemer et alo, 1954) which has been implicated as a humoral 
substance active in natural host defense against infectious 
disease, requires the participation of whole complement for 
its activationo The intimate relationship of properdin and 
complement, and the ability of these substances to participate 
in host resistance phenomena, led to the hypothesis that these 
humoral factors enhanced cytopeptic as well as phagocytic 
activities in addition to their other reported functionso 
The studies to be reported have been conducted in an 
effort to investigate quantitatively the participating roles 
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of cellular and humoral factors in host resistanceo Emphasis 
has been placed on the elucidation of the relationship between 
properdin and complement in the cytopeptic as well as the 
phagocytic process by employing isotope counting techniqueso 
REVIEW OF THE LITERATURE 
In this thesis, the symbols of Pillerner et alo (1956) 
and Kabat and Mayer (1948) are employed as shown in Table 10 
TABLE I 
SYMBOLS AND :f1.'IEANINGS EMPLOYED IN CO:f1.1PLEMENT 
AND PROPERDIN INVESTIGATIONS 
Symbol Definition 
P Properdin 
RP Serum deficient in properdin 
Z Zymosan 
PZ Properdin-zymosan complex 
Cf Complement 
C'l First component of C f 
Cf2 Second component of C' 
Cf3 Third component of Ct 
Cf4 Fourth component of C' 
Rl Serum deficient in e'l 
R2 Serum deficient in Cf2 
R3 Serum deficient in C'f3 
R4 Serum deficient in Cf4 
10 PROPERDIN 
In 1953, Pillemer and co .... workers at Western Reserve 
University reported that zymosan, an insoluble residue of 
yeast cells, required Mg++, heat ... "labile factors resembling 
C'l and C'2 and a hydrazine-sensitive factor resembling C'4 
for the inactivation of C')o Subsequent experiments were 
carried out in an attempt to isolate C'] by eluting this 
heat-stable lipid or lipoprotein (Raffel, 1953) from zymosano 
The experiments were unsuccessful; however, additional in-
formation was obtained concerning the interaction of zymosan 
with C')o Pillemer et alo (1954) reported that zymosan read-
ily inactivated C'3 at 37°C but not at 150Co If fresh serum 
was incubated w'ith zymosan at 15°C and the insoluble 
phase was removed, C'3 could no longer be inactivated by 
zymosan at 37°Co It was further reported that the insoluble 
product obtained by 150C incubation was a complex between 
zymosan and a heat-labile factor; additional evidence that 
C') was not involved in the complex. This complex could be 
dissociated at 37°C in buffer solutions of high ionic strength 
to yield zymosan and the heat-labile factor. This new factor 
was provisionally called properdin, a term derived from the 
Latin perdere, meaning to destroy (Elberg, 1956)e 
Ao Physical and Chemical Properties 
Properdin has been found to be present in all mammalian 
sera tested although in different amountso Pil1emer et alo 
(1954) reported that the rat has the highest titer and the 
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guinea pig the lowest while the human is intermediate. 
Normal human serum contains 4-8 units of properdin per ml, 
but no properdin activity has been shown to be present in 
human spinal fluid, ascitic fluid, pleural fluid, colostrum, 
milk and extracts of white blood cells or plateletso 
The physical and chemical properties of properdin of 
human origin have been determined by Pillemerts groupo 
Human properdin has been purified by di.ssociating the zymosan-
properdin complex with buffers of high ionic strength, fol-
lowed by dialysis, solution and differential centrifugation 
(Pillemer et al,o, 1954; Pillemer et alo, 1956) 0 The purified 
protein is a euglobulin with an isoelectric point between 
pH 505 and 5080 It is stable between pH 4 0 8 and 8e4 at 
ionic strength of 0 0 150 The euglobulin contains lipid, car-
bohydrate and phosphorus, comprises not more than 0 0 03 per 
cent of the total serum proteins, and has a sedimentation 
constant, in the purified form, of 24 to 30 So This large 
sedimentation value suggests a large molecule with a molecu-
lar weight over 1,000,000 or 8 ti.mes that of gamma globulino 
A unit of properdin has been reported to represent not more 
than 0 0 5 ug of protein nitrogen (Pil1emer et ala, 1956) 0 
In serum, properdin is stable to heating at 48°C; there is 
slow destruction of activity at SOoC; complete inactivation 
occurs at 56°C for 30 minuteso In contrast, purified pro-
perdin is stable at 66°C for )0 minutes, but rapidly inacti~ 
vates in 5 minutes at lOOoC o Storage of properdin at -70oe 
results in destruction of activity but storage temperatures 
of 0° or -20oC result in indefinite retention of activity 
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(Pillemer, 1957)0 When the sedimentation constant decreases 
to 3 S, the euglobulin is inactive o Properdin in serum or 
the purified state is stable to freezing and thawingo Pro-
perdin in serum is not destroyed by hydrazine or trypsin or 
by removal of diyalent cations, but is inactivated by traces 
of detergents, soaps, and carbon dioxideo Purified properdin 
does not contain any complement component.s or blood clotting 
factorso In addition, no protease, lipase, amylase, esterase, 
or phosphatase actiyities have been ascribed to the purified 
euglobulino 
Properdin has been reported (Pillemer et alo j 1954; 
Pillemer et alo, 1956) to differ from antibody in many 
respectso Properdin does not have serological specificity; 
it always pr,esent in normal serum; the euglobulin requires 
Ctl, C'4 and Mg++ for complexing; it inactivated by com~ 
plexing with the third component of complement; in serum, 
properdin resides in Fraction 111-10 In contrast to the 
above, Skarnes and Watson (1957) presented arguments sug-
gesting that properdin and natural antibody are likely the 
same substance o These same authors do not subscribe to the 
naming of the antibacterial system as the "properdin system U 
since properdin its represents only one of at least six 
components known to participate in the bactericidal processo 
They suggest also that the terminology of normal or natural 
antibody is ambiguous and should be discarded in favor of 
the term "properdin" unless it can be proved that antibody 
and properdin are distinct substanceso 
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Bo Interactions of the Properdin System 
10 Polysaccharides 0 Originally, human properdin was 
recognized by its ability to complex with zymosan, an in-
soluble polysaccharide mixture derived from yeast cell wallso 
Under controlled conditions this properdin~zymosan (PZ) 
complex was able to combine quantitativel'y wi thand to in-
activate C'30 Two distinct stages have been found to occur 
(Pillemer et alo, 1954; Pillemer, 1956)0 In the first stage 
there is stoichiometric combination of properdin with zymosano 
Cofactors required for this reaction include G'l, C'4 and 
Mg++o Pillemer (1956) reported that this reaction proceeds 
slowly, if at all, at 10C, but rapidly at 150Co Kinetic 
studies by Leon (1956) on the reaction between properdin and 
zymosan showed that PZ was formed from either human or bovine 
serum at 4°C although the reaction time required was 
hours as contrasted to 1 hour if the reaction was carried 
out at l5 0 Co The second reaction involves the PZ combina-
tion with C'3 and thus, inactivation of the third component 
of complement occurs at temperatures above 200 C in the 
pres ena e of Mg +L~ 0 Pillemer (1956) report ed that this react ion 
appeared to be catalytic, that is, the reaction would not 
occur in the absence of Mg++ but the ion was not incorporated 
into the end product. Leon (1957) showed that the formation 
of PZ proceeded optimally at Mg++ concentrations of 
0 0 001 M ~ 0 0 005 1'1; however, the resulting PZ inactivated 
Ct) in the absence of divalent cations. The conflicting 
data was suggested to be due to a difference between Ct 3 
assayed with R3 and C t 3 assayed with EAgpC'l 4 2 or EAhuC'A 
, , 
(the complexes between sensitized sheep cells (EA) and 
guinea pig C' showing the activity of C'l, C'4, and C'2, 
and the complex between EA and human C' showing the activ-
ities of C'l, C'2 and C'4, respectively)o 
Wardlaw and Pillemer (1956) reported that of 22 metal 
ions of the alkali, alkaline earth and heavy metal groups 
tested, only Mg++ restored bactericidal activity of resin-
treated serum in physiologic concentrationso Cobalt, 
manganese and iron also restored bactericidal activity in 
concentrations between 10-2 - 10-3 M; however, these concen-
trations were much greater than those occurring normally in 
serum and the possibility of these ions participat in the 
properdin system were considered remoteo Further studies by 
Wardlaw, Blum and Pillemer (1958) showed that only Mg++, 
Co++ and Dfu++ were able to restore bactericidal activity due 
to the properdin system of serum depleted of cations by ion 
h d Mg++ d b 1 exc ange proce ureso ' was reporte to e quantitative y 
the most effective, ioeo, twice as active as Co++ and 5 times 
as active as'Mn++ on a molar basis o Ca++ was shown to be 
completely inactiveo When Mg++, Co·:"+ or Mn++ was added to 
resin-treated serum at concentrations that restored the bact-
ericidal activity, it was shown that the ability of the 
serum to form PZ at 17°C was also restoredo However, only 
Mg++ or Co+'" was effective in restoring to the resin-treated 
serum the property of rendering C'3 inactive in the presence 
of zymosan and at 370C o IVrn++ was ineffective for the latter 
reaction. As Pillemer (1956) stated "ooQthe interactions of 
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the properdin system are indeed complex, and their signifi-
cance must await further studies along these lineso" Thus, 
resolution of the conflicting reports as to the divalent 
requirements of the properdin system need further experiment-
ationo 
Zymosan is not unique in its ability to form the PZ 
complexo Zymosan preparations isolated bY' DiCarlo and Fiore 
(1958), employing the procedure of Pillemer et alo (1956), 
have been classed as types A and B on the basis of serological 
activit yo Composition studies of the two types revealed that 
zymosan is composed, on the average, of 54.7 per cent glucan, 
180$ per cent mannan, 1405 per cent protein, 606 per cent 
fat, 302 per cent inorganic material, and 0 0 8 per cent 
chitin on the basis of accounting for 9806 per cent of the 
hydrolyzed materialo The analytical differences between 
type A and type B were no greater than the variations noted 
among different type A preparationso These authors concluded 
that the difference in serological activity of types A and B 
cannot be due to gross chemical composition, and they suggested 
that surface structures and charges determine zymosan activit yo 
Pillemer et alo (1955 ) investivated the mechanisms 
of action of properdin with zymosan and of properdin with 
various bacteria and other agentso It was found that all 
polysaccharide-properdin complexes did not inactivate C'], 
however, the majority of the reactions resulted in the agent 
complexing with properdino Among some of the agents tested 
were bacterial cell walls, endotoxins and lipopolysaccharides, 
dextrans and levans from bacterial filtrates, and lipopoly-
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saccharides, polysaccharides and mucins of mammalian tissue 
origin. These substances were all highly branched and had 
molecular weights of 107 or greater. No correlation was 
shown to exist between the toxicity, pyrogenicity and anti-
genicity of these substances and their ability to interact 
with properdin. Pillemer (1956) stated that no correlation 
existed between the activities of these substances and any 
physical or chemical property. It was shown that polysac-
charides of very similar structure and identical polymer 
units exhibited widely different activities. The active 
materials contained both ~ and)9 linkages, pyranosidic and 
furanosidic units, and a variety of interhexose linkages 
within the same compound. The various activities were present 
regardless of the presence or absence of lipids or proteins. 
In vivo experiments by Landy and Pillemer (1956) have shown 
that as little as 1 to 10 ug of bacterial lipopolysaccharides 
caused a marked elevation in properdin titers in mice. 
Similarly mammalian polysaccharides caused elevated properdin 
levels in very small amounts. It was suggested that 
serum properdin levels may be the result of stimulation or 
depletion of properdin by both bacterial and host products. 
2. Bactericidal reactions. Ross ~ ale (1955) and 
Pillemer and Ross (1955 ) reported that the intravenous in-
jection of zymosan into mice resulted in a marked initial 
decrease in serum properdin levels that was followed by an 
increase that was dose-dependent. The initial decrease in 
properdin levels was proportional to the dose of zymosan 
administered, however, the subsequent rise in titer was 
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inversely proportional to the dose, ioeo, the smallest dose 
resulted in a very pronounced elevation while the largest 
dose resulted in a return of properdin titers to less than 
original levels present over a 10 day test periodo R.owley 
(1955, 1956) showed that polysaccharides derived from Eo coli 
cell walls, as well as zymosan, resulted in altered resistance 
of mice to subsequent Eo coli challengeo It was suggested 
that since Eo coli polysaccharides would react with properdin 
in vitro, similarly to zymosan, that the decreased levels of 
properdin caused by the injection of Eo coli polysaccharide 
in vivo could account for the susceptibility of the mice to 
the bacterial challenge o 
The bactericidal activity of the properdin system 
was investigated by Wardlaw and Pillemer (1956)0 Some 44 
strains of a variety of species of bacteria were testedo It 
was shown that twenty strains were killed in fresh serum and 
by serum deficient in properdin (RP) to which properdin 
was addedo These strains were viable in RP alone and clas .... 
sified as susceptibleo Fourteen strains were viable in 
serum and RP plus properdin and were classified as resistanto 
Ten strains were killed in RP alone, as well as in serum and 
RP plus properdino These ten strains were viable in properdin 
alone and were classified as unknowno The strains tested 
included Shigella 2£0, Salmonella £20, Eo coli, Ao aerogenes, 
Proteus §Qo, Pseudomonas ~o, Paracolobactrum §Qo, and 
B. subtilis. Properdin proved to be inactive against 
Staphylococcus aureuso The presence of specific agglutinins 
in serum interfered with the bactericidal activity of pro~ 
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perdin against Shigella dysenteriae. The bactericidal activity 
of the properdin system was shown to occur optimally in concen-
trations between 1 and 10 units per ml RP in vitro. As little 
as 0.01 unit per ml of RP showed definite bactericidal effects. 
Concentrations of properdin above 10 units per ml RP were 
inhibitory, i.e., a concentration of 60 units of properdin 
per ml showed less bactericidal activity than a concentration 
of 1 unit per mI. 
Blattberg (1956) was able to increase the bactericidal 
activity of rabbit and guinea pig serum for E. coli B by a 
series of subcutaneous injections of zymosan suspended in 
egg-white and incorporated in Freund adjuvants. These animals 
responded to intracutaneous zymosan injections by exhibiting 
the Arthus phenomenon. Since zymosan absorbed the bactericidal 
activity of the sera without affecting the hemolytic activ-
ity, it was proposed that the properdin fraction of the 
serum contained the substances which destroyed the bacteria. 
Landy and Pillemer (1956a) observed a transient in-
crease in properdin levels of mice treated with small amounts 
of purified lipopolysaccharide derived from Salmonella 
typhosa. If the mice were injected with small amounts (1-10 ug) 
of the lipopolysaccharide (intraperitoneally or intravenously) 
24 hours before challenge with certain gram negative organisms 
the mice were non-specifically protected, whereas the controls 
showed decreased properdin levels and died. Rowley (1955) 
had previously shown this protective effect by injecting 
E. coli cell walls into mice prior to challenge. Rowley 
noted that a highly susceptible state existed within 2 hours 
after injection of the c walls, but an ed resist..:.. 
ance to infection resulted if the challeng~; of organisms was 
given 24. hours later. Row1ey stated that no alteration of 
serum complement levels occurred during th time. 
Ross (1958) reported that serum properdin levels of 
mice were markedly decreased and that· death resulted "'Then· 
the mice were injected intraperitoneally with large numbers 
of viable E. coli. He was also able to show increased 
resistance to K. ~neumoniae challenge if the mice were pre-
treated with zymosan. This nonspecific increase in resistance 
persisted in the mice for as long as 3 months after a single 
zymosan injection. Such treatment resulted in immediate 
decrease in properdin levels to a minimum in 2 hours, fol-
lowed by an above normal level which lasted about 10 days. 
Increased resistance persisted despite the return of properdin 
levels to normal. It was also shown that purified human 
properdin administered intravenously into mice 2 or 4 hours 
before intraperitoneal challenge with K.· pneumonia.~ resulted 
in marked protection. Of interest was the fact that t.he 
heterologous properdin was rapidly destroyed in ~ in 2 to 
24 hours. In an addendum to the original paper, Ross stated 
that he was able to protect mice against K. pneumoniae in-
fection with both heated (lOOOe, 30 min.) and undenatured pro-
perdin solutions. 
Landy and Pillemer (1956b) were able to correlate the 
maintenance of, or increase in, serum properdin levels with 
increased resistance of animals to gram negative bacterial 
challenge doses, i.8. 9 small doses of lipopolysaccharide 
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completely protected the animals when the challenge dose was 
administered 6 to 24 hours later. This correlation was 
not always exact, and in a few instances the properdin levels 
were merely maintained in test animals that showed increased 
resistance. It was concluded that other mechanisms of defense, 
in addition to properdin were active following lipopolysac-
cha.ride injections. More recently Rowley (1956) showed that 
a correlation between increased resistance of mice to infection 
and the bactericidal power of their serum existed following 
administration of E. coli 0 antigen. The pathogenic strains 
of E. coli were shown to be more anti-complementary than 
the nonpathogenic strains because of the increased content 
of 0 antigen. It was supposed that a substance like properdin 
could be involved in the mechanisms. 
Alteration of properdin levels has been shown to 
occur with mammalian tissue polysaccharides as well as bact-
erial products (Pil1emer, Landy and Shear, 1957). Resistance 
to infection was again correlated with properdin levels. 
Recently Wood and Ono (1957) and Wood, Ono and Bessey 
(1958) described a method whereby antibacterial activity of 
sera on the test organism, B. subtilis, could be measured 
using the Vlarburg apparatus. It was found that components 
other than antibody were responsible for inhibitory effects. 
Inactivation of complement by heating the serum (56°C) re-
moved part of the total inhibitory property. Subsequent re-
addition of complement restored the complete inhibitory prop-
erties of the serum. It was suggested that the complement 
dependent system was properdin. 
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Dubos and Schaedler (1956) observed an increased 
capacity of mice to resist challenge of gram positive 
organisms if lipopolysaccharides were administered prior to 
challenge. With the exception of one strain of B. subt.ilis 
(Vvardlaw and Pillemer, 1956) gram positive organisms are 
resistant to the properdin system in vitro, and Dubos and 
Schaedler concluded that other defense mechanisms were activated 
by injection of the material. These same investigators 
(Schaedler and Dubas, 1956) have shown that increased suscept-
ibility to lnfection resulted when the host is in a starved 
state. They concluded that the starvation period did not 
lower properdin levels and thus an active infection was initi~ 
ated even in the presence of bactericidal concentrations of 
properdin. These authors used mice in their experiments; 
however, since the properdin system requires Mg++ and the four 
components of complement for its activation, and since the 
mouse serum has been reported to lack certain complement 
components (Brown, 19h3; Rice and Crowson, 1950; Pillemer, 1956) 
and also exhibits no bactericidal effect (Marcus ~:~. a1., 1954) 
then it is conceivable that an infection could originate in 
the mouse in spite of bactericidal concentrations of properdin 
in the serum. Landy (1956) showed that increased resistance 
following administration of lipopolysaccharide extended only 
to gram negative ba.cteria while changes in susceptibility to 
three species of gram positive organisms could not be demon-
strated. 
These observatj.ons of non-specific protection against 
infection by administration of killed organisms or injection 
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of extracts are not new. As early as 1893 Klein first observed 
that injection of various killed. heterologous bacteria, either 
intraperi toneally or subcuta.neously prior to challenge 'wi th 
lethal doses of Gholera bacteria, protected the animals. 
Issaeff (1894) and Pfeiffer and Issaeff(1894) were able to 
protect guinea. pigs against lethal doses of cholera organisms 
if the anima.ls were treated preYi.ously with intraperitoneal 
injections of broth, peptone or urine. A marked leucocytosis 
'was observed in the body cavity at the time of challenge, and 
these investigators thought the increased resistance was due 
to the release of bactericidal material from the leucocytes. 
Bedson (1915) injected a.utolyzed bacteria intravenously into 
animals and found that ~'lith.in a :<; hour period following in,"" 
as W "11 as l(,:,,"coc~r'1-' c" .... l· , ... ,~ • .... i..'. j ·oJ I Ii:) ., • This incX"l3as:jd opsonic act.i.vity was 
serum at 56°C, and disappeared from the serum aftdr 24 hours. 
IIiss (1908) injected leucocytic extracts intraperitoneally into 
animals and found that this treatment protected the animals 
aga.inst c:t1allenge wi.th I:.'r')th. gram positive and gram negative 
organisms. A massive leucocytic infil:cration was observed In 
the protected animals. \:\7hen 1tlTright (1931) inj i3cted animals 
with vaccines prepared from gram positive bacteria, an increase 
in bactericidal and phagocytic activities was observed. 
Furthermore!, when these vaccines were added to norma.1 serum 
in vitro, an incr(,3!ase in bactericidal pO'Aler was noted. These 
changes were attributed to the release of opsonin from the 
damaged leucocytes. 
It see~s evident that c-;ct ion ific materi 
stimulates many host defenseso 
3. Yiruses,o In 19h9, 3berg H demonstra.t 
that inhibition of influenza, e~castle disease 
viruses by normal se~lm a .-c tor, 
a:i.l components of comp1.ement and a ent cation (thought 
to be Ca++ at that time)o investigation showed 
that the unknown heat..-la.bil,a factor ':'fl;'as probably properdin 
and the diva.lent cation to be magnesi'J.m (Wedg-wocd, Ginsberg 
and Pillemer, 1956~ Ginsberg and vvedgwood, 1956; Wedgwood 
and Pillemer, 1958). Experimental results showed that. the 
properdin system can be equated to the heat-labile factor 
by the follo111Ting criteria~ (1) corresponding temperature 
dependence, (2) adsorption properdin or heat .... labile 
factor without significant complement titer redl:~cticn, 
and (3) reactivation of virus by reducing the availability 
of magnesium to the system. 
l>Tewcastle disease vi.rue inhibition, within limits" 
V.ras directly proport.ional to tl'18 properdin c~ncentratlL'no 
Optimal inhibition occurred bett~;''i:1en :20'5 and 5 units of 
properdin per ml of RP. Pro}.;erdin concentrations of 10 
units per ml of RP or greater appear~~d to be detrimental 
to the virus inhibition reaction (Wedgw-ood, Gi.nsburg and 
Pillemer, 1956). 
According to v'YedgvJ'ood and Pil1emer (1958) all 
viruses are not susceptible to the properdin system. 
The polio virus was ma,rk,2dly resistar:t~ However, it has 




.1. n 1 lC:."'"'' I.D, 
i,:llen. .seru.m 
depleted of properdin lY'ucid 
upon ~ ion of rnxr-ifted 
~;eru:rn. nu to b es 2'D t 
reaction. 
cffect3 of whole 
body irradia~ion on erum properd of rats mic 
were studied and ss '1'''.1:5' ) 1 .';1 ) ano. ss 
found that total body ion of rats 
r) result in 2erum properdin 1 ~apidly falling 
to less than 30 o The 
gracluall'.Y' returned to n(.:'21""-norma.l within a 
weeks ing on the dosage of irradiation originally 
administered. During the same period 'whole complement 
titers and ccmplement compone:n't te~s were elevated, with 
the exception of ?l and The C \'J t increased 
most :l.n magnitude$' io8o; 3 nOT-walo Linder 
(1957) reported that rats expos to 500 yo 'who1e body 
rad t ion sho·wE.:d decreas ed sey"'u.m properd :tn :.evels of 93 
per c E;~nt of on the fi.X'st po!st""lrradia.tion day, 52 
per eent of normal ~n the th:i.rd post-> tr-radi.a.tion day, and 34 
cent of c~ri 'the ei.ghth -irra.diat ion dc~:r 0 After 
the mini.mum level \fJ'as r8ached on the eighth post .... irradiati.on 
day, the level rose to 60 per cant of normal by the thirteenth 
post~irradJation d.3.yo 
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This rapid decrease in properdin levels can be 
partially explained by the fact that properdin only com-
prises 0.02 per cent of the total serum proteins and has 
an in vivo half life of 48 hours (Keller, Isliker, and Aebi, 
1957). Since a cell is necessary for production of anti-
body and also properdin, then depression of activity or 
total inactivation of the cell as a result of irradiation, 
can make the explanation obvious. 
Since bacteremia is one of the greatest causes of 
death in whole body irradiated animals, the value of properdin 
as a therapeutic agent was investigated by Ross et al. (1955), 
and Ross (1956). The intravenous injection of purified bovine 
and human properdin into whole body irradiated rats and mice 
was reported to significantly protect the animals against 
LDIOO/30 day and LDIOO/6 day doses of irradiation. The degree 
of protection was dependent on the dose, route, and time of 
administration of properdin. Animals treated on any post-
irradiation day but the fifth day exhibited survival rates 
similar to or more accelerated than the controls. Animals 
treated on the fifth day showed a four-fold increase in 
survival rate. Properdin-treated mice exposed to 820 r 
whole body irradiation were reported to have gained weight 
and remained healthy up to 3 months after exposure. Ross 
et al. (1955) used zymosan in other irradiation experiments. 
It was reported that the intravenous injection of zymosan 
into rats and mice caused an initial reduction in serum 
properdin levels followed by a return to normal or above 
normal levels. Zymosan injected into animals before or 
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after exposure to irradiation increased or decreased the 
lethal effects of irradiation, depending on the time, dose 
and route of injectiono Other high-molecular weight poly-
saccharides also partially protected the whole body 
irradiated mice when administered prior to exposureo 
Conversely, Haley et alo (1956) could not demonstrate the 
beneficial effects of zymosan in treatment of irradiation 
injury. These authors concluded that zymosan in the doses 
and modes of administration employed, was not beneficial to 
irradiated mice. Recently, Hardin et ale (1958) reported 
that survival of CFW mice exposed to whole body irradiation 
was enhanced by administration of human blood serum or 
saline. The results were attributed to supportive effects. 
\fuole blood was reported to be no more effective than serum, 
and saline was found to be as effective as serum. The pro-
perdin system was reported not to enhance survival rate. 
5. 11iscellaneous reactions of the properdin system. 
Pillemer, Hinz and Wurz (1957) were able to prepare and 
characterize an antj:"hwaan properdin rabbit serum. The anti .... 
body was stable to heating at 56°0 for 60 minutes, properdin 
was inactivated almost instantaneously by the antibody at 
either 37°C or lOCi and the antiproperdin activity was 
removed by adsorption of the serum with PZ complexes, but not 
by either RP or zymosan. The authors suggested that in view 
of their results the use of properdin of heterologous 
origin for in vivo experimental work was undesirable 
because of the antigenic nature of properdin. 
The relationship of the Toxoplasma antibody act-
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ivator to the properdin system has been investigated by 
Gronroos (1955) and Feldman (1956)0 Six years before the 
discovery of properdin, Sabin and Feldman (1948) reported 
that a heat-labile serum component ("activator") w'as neces~ 
sary in order for neutralizing antibodies to act against 
Toxoplasma gondii o Human serum was used as a source of 
activator since, in the absence of antibody, the serum 
was without effect upon the parasiteo The role of various 
co-factors was investigated and it was shown that all four 
components of complement Mg++ were necessary for the 
Toxoplasma antibody to act on the parasite o After the 
properdin system was reported by Pillemer et alo (1954) 
the activator was restudied by Gronroos (1955) and Feld-
man (1956) from this point of ewo Gronroos concluded 
that the activator is composed of properdin and C'2, C'3, 
and C'4o In addition, Mg++ was also assumed to be requiredo 
Feldman (1956) reported that complement or Mg++ alone did 
not enhance the activity of the antibody. Furthermore, 
it was reported that excess concentrations of properdin 
added to RP resulted in inhibition of the reaction, a 
situation similar to that reported for bactericidal and 
virus inhibition studies (Wardlaw and Pillemer, 1956; 
Ginsberg and Wedgwood, 1956)0 In view of these experiments 
it would appear that the heat-labile serum factor called 
"accessory factor" by Sabin and Feldman (1948) is similar 
to, not identical with, the properdin system; however the 
role of C'l remained obscureo 
Recently the hypothesis was suggested that properdin 
em component s O~y'erE: nons ific i.nhibitor.s 
of hyaluronidase in normal serum I) Hadidian, l'/Iahler 
and Hurphy (1957). A number striking similarities existed 
such as~ (1) NSI was thermolabile, pro sensitive and 
quantitatively precipitat from solut of low ionic 
strength at pH 5. o5~ (2) the action of NSI on hyalur .... 
• • .'.J,. C ++ ( ) onl.dase requlred Mg' or 0 ; and 3 NSI actio n on 
hyaluronidase was inhibited in solutions of high ionic 
strengthe However, and contrary to expectations, exper .... 
iments conducted with zymosan showed that NSI could not be 
ident ed with properdin. Furthermore, the serum fron 
hyaluronidase injected rabbits (a procedure that removed 
NSI) showed no loss of C' activity; thus NSI could not be 
identified with any c t component. A similarity of NSI 
with properdin was noted vihen lipopolysaccharide was in ..... 
jected into guinea pigs. There was an increase in titer 
of NSI in the serum due to treatment kno'Wrl to increase 
properdin levels in serum. 
In 1958~ Tauber and Garson investigated the effect 
of cortisone, properdin and reserpine on N. gonorrhoeCi.~ 
endotoxin activit yo Cortisone was reported to protect 
mice from death due to N. gQJLorrhoeae endotoxi.n. When 
relatively large doses of properdin were used, results 
similar to those with cortisone were obtained. However, 
reserpine significantly enhanced the endotoxin lethality 
under certain conditionso 
In 1957, Rowley briefly revie1,..yed the properdin 
system and its role in immunity. In the discussion 
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lnvolv\jd in human 
Q 
that properdin system could be 
S(?Etsei!fa,::~ reported by Hinz, Jordan and 
llemer (1956a), Hinz, lr::;man and Hurley (1956b), and 
Hin:z (1956) 0 These inv(;stigato',r,s found that IIg++, fa1jtors 
T"esc;mb] ing complement COmp(1nents, and properdin Vl::3T'f~ rt~qui 
for the .Y:.illQ hemolysis of a,bnormal erythrocyties .?rom 
patients t'V'ith a form of chronic hemol:~ltic anemia knovm as 
paroxysmal nocturnal hemoglobinuria (PNH) 0 l'~o antibody '1\?:lS 
required for this reaction, indic ing that the red blood 
c is defective o Hir::z 2 ,9.10 (1956a) reported that normal 
human serum hemol~l'Zed the 
properdin (HP) or serum 
cells, but serum king 
king any of the complement (C r ) 
components failed to hGmol:,yze 'the PNH cells o The C).dditiorr 
of properdin to TIP restored the hemolytic activity of the 
serum, but prop(~rdj .. n~3.dded to serum lacking G" components. 
did not lit yo The requirement 
for l~g++ '"(lEiS '("at of different ion] 
to serum that ~iS sed t.hrough G i0n exchang(:? re:::: • 
a++ did not restor:~ the hernolytic iv-l.ty 105 x 
restoration of 
in tot;al ionic ::3 
7) report 
rg":~+ I~oncent,ratio:n resulted in cornplete 
h0molytie activity. Excess ]''1g++ result c:d 
ion, lbly because of an Incre&,se 
o ently, Ii z, Abraham and 1lener 
normal human red bIood c s could 
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hemolyzed in vitro with human serum if pretreated with tannic 
acid (TA). Although similarities existed between this 
reaction and the hemolytic reaction of PNH cells, some dif-
ferences were apparent. The cofactors required for hemolysis 
of TA cells or PNH cells include properdin, I'1I1g++ and C' 
components. In contrast hemolytic reactions involving 
isohemolysins and panhemolysins required specific antibody 
and C', but were stated to not require properdin or magnesium 
(Hinz et al., 1957). The differences between TA cells and 
PNH cell hemolytic reactions included: (1) TA cells agglutinated 
spontaneously whereas PNH cells did not; (2) TA cells spon~ 
taneously hemolyzed after exposure to low temperatures but 
PNH cells were stable in the cold; and (3) TA cells lysed 
optimally.in normal serum at a pH of 7.4 while PNH cells 
lysed optimally at pH 6.8. The degree of TA cell hemolytic 
reaction was found to be directly proportional to the amount 
of purified properdin added to RP; however, when whole serum 
was added to RP varying amounts of hemolysis resulted. Thus, 
while the TA cell hemolytic reaction could be used to assay 
purified properdin, it was not a reliable quantitative test 
of properdin in serum. 
Recently Crosby and Benjamin (1958) were able to 
inhibit the in vitro hemolysis of PNH cells by the addition 
of dextran to the serum. Although the inhibition was not 
marked) it was accomplished with clinically reasonable con-
centrations of dextran. One mechanism of action suggested by 
the investigators was that the properdin preferred the dextran 
molecule over the p~m cells and thus was unavailable for the 
hemolytic react • Stratton, ~(lilkinson and Israels (1958) 
employed dextran infusions on 2 pat S 'V\I'ith PNH. In both 
cases the treatment i/'laS Slleces in that the hemoglobin'IJ.ria 
ceased. The results indicated that more clinical experimen-
tation be attempted since PNH occasionally stops spontaneous 0 
Hinz (1956) reported that normal properdin levels 
have been obtained from patients with chronic recurrent in-
fections in which gamma globulin levels are normal and also 
in other afflictions such as bronchiectasis, hepatic cirrhosis, 
acute leukemia, diabetes, nephrosis, and agammaglobulinemiao 
With regard to agammaglobulinemia, Barandun and Isliker (1956) 
and Soulier and Menache (1958) have reported that low pro-
perdin values were found in patients afflicted with this 
disease. However, the former authors stated that their 
assay techniques may be imperfect and thus may be respon-
sible for the large variations in properdin levels observed. 
Furthermore, it was reported by Hinz (1956) that steroid 
treatment did not change the properdin levels of patients. 
Other patients in whom normal properdin levels were ob-
served included: (1) patients who were markedly malnourished, 
(2) those who had myocardial infarctions, and (3) patients 
afflicted with tuberculosis and rheumatoid arthritis of 
acute and chronic nature. In contrast to the results 
reported by Hinz for the last named disease, Laurell and 
Grubb (1958) reported that sera from 8 patients with 
rheumatoid arthritis assayed less than 1 unit of properdin, 
while pro zones were observed in the other 5 samples tested. 
These authors stated that their results confirm the work 
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of Eyquem and Tullis (1957) that properdin titers are 
frequently low or non-determinable due to prozone phenomena 
in the zymosan assay procedureo Perhaps the different 
properdin levels obtained by Laurell and Grubb (1958) 
and those reported by Hinz (1956) can be attributed to 
technical details. 
Hinz (1956) reported that low properdin levels were 
found in patients infected with gram negative organisms, 
PNH, and pneumococcal pneumoniao He also stated that normal 
levels of properdin were found in patients with various 
localized and metastatic malignancies including both 
lymphoma and carcinomao In contrast, serum properdin 
level studies by Rottino and Levy (1957), Southam and 
Pillemer (1957), and Rottino, Levy and Conte (1958) had 
shown low concentrations in patients with epidermoid 
cancer, adenocarcinoma, and sarcoma; normal amounts were 
reported in patients with Hodkin's disease, chronic 
lymphatic leukemia or lymphosarcomao 
Properdin level studies have been carried out by 
several investigators in other fieldso Data by Benson 
et ale> (1955) showed that properdin levels are not in-
fluenced by anesthesia or uncomplicated surgeryo No 
changes were observed following splenectomy or adrenalectomyo 
An interesting study was carried out on patients who received 
localized radiotherapy to various parts of the body with 
doses as high as 3000 ro In each case no properdin level 
changes occurred as a result of treatmento 
Wiss, Weber and Isliker (1957) reported that serum 
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properdin levels of the rat 'were markedly decreased as a 
result of pantothenic acid deficiency but the level re-
mained uninfluenced by vitamin deficiency. The deficiency 
symptoms (reduced growth, disturbed acetylation abi.lity, 
decrease coenzyme A concentration in the liver, and low 
properdin levels) were intensified by the addition of a 
pantothenic acid antagonist called sodium DL-UJ-methylpantothenic 
aci.d. 
In cases of hemorrhagic shock, one of the causes of 
death has been attributed to endotoxemia or bacteremia. 
Properdin levels in dogs were determined before and after 
induced hemorrhagic shock by Frank, Fine and Pillemer (1955). 
The dogs showed a distinct decrease of properdin in their 
serum Nithin 1 to 2 hours after the induced bleeding. 
The reduction was more marked later in shocko The pro-
perdin titer remained at a minimal level despite blood 
volume deficit corrections later in the shock period. 
No significant changes in C' titers -were eV'ident. 
A study by Lowbury and Ricketts (1957a, 1957b) of 
the properdin system in patients who had been burned 
showed that the properdin concentration is reduced in the 
serum. However the bactericidal capacity of the sera 
against a properdin sensitive Shigella organism from patients 
with no detectable properdin was in the same range as the 
sera from normal controls containing definite amounts of 
properdin. Se-veral strains of gram negative bacteria 
isolated from burn wounds were found to be resistant to 
the bactericidal action of serum,. It was suggested that 
due to the e of ':;J~ ,~3.rit organisms 
'in burn \-vound I properdin \fIras !:;ot a ant factor in 
protecting burns i,nst gram To' ive terial infectiono 
was:ruite possi'ble tha.t serum properdin level 
of burn patients increa;:: susceptib ity to infection 
by organisms normalJ..y killed the 
authors stat th,at since appearved that properdin 
system could not kill the bact al flora in established 
burn i.ons, it would not. be us as a therapeutic 
dgen t 81.1 though properdin Pl"'O bably an important co"" 
factor in the defense mechanisms of uninfected tiSSU8 0 
v.;'eld and Kean (195 $) report ed that 1f2.£p.omona§. 
y,gginaJJJ! were killed iAthen injected intravenously into 
rabbitf>o S'ubsequent in vitro experiments sho'wed that the 
blood itself was trichomonicidal altb.ough the reticula .... 
endothelial system vIas probably active in ridding the blood 
of many organisms in vi~., The in vitro study IN'aS con-
duc:ted on 54· serum specimens obtained fr"om humanG as well 
as :frorn guinea pigs, rats, hamsters, and rabbitso 
each case the serum specimens had the capacity to kill 
and the organism although the timE-) req'Uir'ed var"ied. 
The rat and rabbit s'era completely' ed the orgainism 
by the human, rabbit, guinea J;ig and hamster serao The 
to a tem"" 
perature of 560 c for 30 minutc39 Implic ion of the 
properdin system in this trichomonic 
discussed since the and rabbit have eonc:idera.bly higher 
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properdin levels than the other species sera tested {Pille-
mer al, 1954; Pillemer et alo, 1956)0 
Recently DeWitt (1958) studied the differ2ntial 
effect of hog gastric mucin on properdin and ho resistance 
to infection" Although considerable variation in infection-
promoting ability and in vitro antiproperdin activity 
was observed among different mucin samples, all the samples 
examined possessed uniformly high in vivo antiproperdin 
activityG Concomitant with the antiproperdin acti.vity, 
distinct changes in host resistance to infection were noted, 
but the relationship was not causally relatedo It was sug-
gested that the ability of hog gastric mucin to increase 
the virulence of certain infectious agents can be ascribed 
to the n ••• result of a complex interaction of numerous effects 
directed primarily against the host.n (DeWitt, 1958) 
Herbut and Kraemer (1958a) extended and substan-
tiated the work originally reported by Kidd (1953) concerning 
a tumor inhibitory factor present in guinea pig serum. 
The factor was found to be active against lymphosarcoma 
6C3HED in C3H mice and lymphoma II in strain A mice while 
the appearance of r\l1urphy-Sturm lymphosarcoma in Wistar rats 
was delayed. The guinea pig serum was administered in-
travenously daily for six days or 3 times a week 4 days 
after tumor implantation (tumor approximately 8 rom in 
diameter at this time). Guinea pig serum treated mice 
showed complete regression of tumor while, in the amounts 
employed, ra~ chicken, dog, bovine, horse, calf, rabbit 
sera and human or sheep plasma did not exhibit tumor in-
hibit6ry propert o Properdin levels of serum from 
treated mice showed that the levels were low when the tumors 
were la.rge, and normal or elevated when the tumor regressed. 
rrhus it v{ould appear that the pr(~<perdin system of the host 
was involved in controlling the tumo~c gro'wth or at least 
in reflecting its activity. The turnor inhibitory factor 
was concluded not to be properdin sin~e all of the sera 
tested possessed properdin titers equal to or greater 
than guinea pig serum and none showed the activity of the 
guinea pig serum. 
More recent studies on the tumor inhibitory fa.ctor 
of guinea pig serum by Herbut, Kraemer and Pillemer (1958) 
have shown that complete regression of lymphosarcoma 
6C3HED in C3H mice occurred with (1) normal guinea pig 
serum, (2) guinea pig RI, (3) guinea pig R3, (4) guinea 
pig R4, (5) guinea pig RF, (6) heated guinea pig serum 
(560 C for 20 and 60 minutes; 66°c fo)'" 30 minutes), and 
(7) with supernatant from centrifuged guinea pig serum 
(35000 g, 2°C, 3 hours) 0 No tumor inhibitory effect vIas 
noted ~Tith guinea pig R2 and the lipopolysaccharide pellet 
from ultracentrifuged serum. The results indicated that 
the inhibitory factor is not whole complement, lipopoly .... 
saccharide properd:i.no Preparations of properdin exhibited 
no adverse tumor inhibition even when used in conjunction 
with new inhibitory amounts of guinea pig serum and 1,'Ig++ 
(Herbut and Kraemer, 195$a)o 
The effect of zymosan in stimulating the host 
defense mechanisms against Sarcoma 180 in mice was re-
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ported by Bradner, Clarke and Stock (1958). Intraperitoneal 
injection 24 hours after tumor implantation of zymosan in 
low doses (5-20 mg/kg) in divided daily doses for 7 days 
(total of 13 injections) or 2 daily doses were shown to 
promote a significant degree of tumor loss. In contrast, 
zymosan doses of 80 to 160 mg/kg were non-effective. The 
zymosan was suspended in 0.5 per cent carboxymethyl-
cellulose-normal saline diluent. The diluent control 
showed no inhibitory action by itself. Zymosan was tested 
against Sarcoma 180 and normal mouse connective and 
epithelium tissues in tissue culture. No direct cytotoxic 
effect was observed as assessed by mitotic counts and 
numbers of degenerate nuclei. Therefore the tumor loss 
phenomenon appeared to be entirely mediated by the host 
as an immune reaction. Correlation studies between the 
properdin levels and tumor growth indicated that pro-
gressive tumor growth was attended by a significant decrease 
in serum properdin levels. In this connection it was 
reported that carboxymethylcellulose interfered with the 
properdin assays as performed by Dr. L. Pillemer's laboratory. 
Recently Mankowski ~ al. (1957) reported on the activity 
of zymosan in promoting recovery of mice bearing Sarcoma 
37. Similar results were obtained by Bradner, Clarke and 
Stock (1957), who found that zymosan caused regression of 
Sarcoma 180 in mice. 
The conditioning of rats with injections of small 
doses of zymosan to a transplantable human carcinoma of the 
colon (HR132) was reported by Herbut and Kraemer (195Sb). 
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These investigators did not carry the heterologous cancer 
transplant for more than one generationo In most in-
stances serial propagation of heterotransplanted cancers 
have failed in hosts conditioned by irradiation and 
cortisone. In an attempt to serially propagate heter-
ologous tumors in rats treated with zymosan, Jude and 
Schaten (1958) showed that the intravenous administration 
of zymosan was ineffective in decreasing resistance to 
heterologous tumor growth. Among the tumors tested were 
Sarcoma 37, Krebs ascites, Sarcoma 91, lymphosarcoma 
C3HBA, and HeLa. Zymosan alone was ineffective and the 
combination of zymosan (150 mg/kg) and cortisone (3 mg) 
was as effective as cortisone alone indicating that 
cortisone by itself is the agent responsible for host 
resistance alterations. In 1956 Mathe and Bernard were 
able to transplant mouse leukemia 1210 in the hamster 
if they pretreated the hamster with zymosan, cortisone 
or x-irradiation. Therefore the role of zymosan in 
conditioning of animals in heterotransplants needs 
further investigation. 
Levan had been reported by Pil1emer et al. (1955) 
to alter properdin levels in vivo, and Brenner, Wentz 
and Ecker (1958) investigated the effect of levan on 
transmitted mouse leukemia. Available evidence 
indicates that mouse leukemia is caused by a virus, 
and the properdin system has been reported by Pillemer 
et al. (1956) to neutralize and inactivate certain viruses. 
Hice (058) treated with 5 mg of levan intraperitoneally 
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were not able to alter the course of transmitted leukemia, 
and CFW mice treated intravenously or intraperitoneally 
with levan failed to inhibit or enhance the establish-
ment of a solid phase Erhlich ascites tumor given sub-
cutaneously. The properdin system apparently was not 
activated by the levan treatment or had no effect ort ihe 
two diseases investigated. 
The role of properdin and renal homografts was in-
vestigated by Hubay and Persky (1957). Zymosan in doses of 
5-10 mg/kg administered intravenously to mongrel dogs 
depressed the properdin levels to 3 units per ml or less. 
A renal homotransplantation was then carried out in the 
neck by direct anastomosis of the carotid and renal 
arteries, and the renal and jugular veins. The length 
of survival of the renal homografts varied from 24 hours 
to 8 days. The properdin levels were satisfactorily 
depressed during the life of the homotransplant. It was 
concluded that the preliminary experiments did not permit 
any conclusive statement concerning the acceptance of 
renal homografts and the properdin system, and further 
work was necessary for further clarification on the role 
of the properdin system in the injection of tissue homo-
transplants. 
D. Isolation of Properdin 
In order to adequately study the physico-chemical 
and biological interactions of properdin, it was desir-
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able to obtain as pure a preparation as possible. Orig-
inally properdin was isolated by Pillemer et ale (1954)0 
The procedure involved the adsorption of properdin to 
zymosan in the presence of other serum factors and Iv1g++ 0 
Elution of properdin from the zymosan-properdin complex 
was accomplished by buffers of high ionic strength e 
Subsequent dialysis and differential centrifugation would 
yield a product containing 2000 units per mg nitrogen 
(Pillemer, 1956). I'·:lodification of the procedure by Todd 
and Pillemer (1958)·resulted in properdin solutions of 
comparable activity, however, the amount of reagents 
employed at certain steps in the preparation were 
decreased. 
Since different zymosan preparations exhibited 
non-uniform activity relative to properdin adsorption 
(Pillemer et al., 1956), the activity of purified properdin 
solutions varied considerablyo Furthermore the cost of 
zymosan prohibited any large scale operationso Also 
since human plasma was more readily available than human 
serum, isolation of properdin from plasma' was successfully 
attempted by Pennell et al. (1957). + .. ,-The r,!Ig . ion con-
centration necessary for zymosan adsorption of properdin 
from plasma was adequately insured by addition of l\~g++ 
to a concentration of 10-3 M to resin-collected plasma, 
or by saturating the ci trate ions with added rl1[g++ which 
led to the liberation of Ca++ ions (the association con-
stant for calcium citrate complex being smaller than the 
constant for magnesium citrate). The liberated Ca++ ions 
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were prevented from participating in the coagulation 
process by prompt adsorption of prothrombin onto BaSO,+. 
Furthermore, these authors were able to recover properdin 
from Fraction I without the use of zymosan pilot 
experiments. Extending these fi.ndings, Spicer et ale 
(1958) prepared large quantities purified properdin 
by analysis of the various fractions of the Cohn process, 
particularly Fraction I. The properdin activity ~~jas found 
to be present in a glycine-buffer extract 'V\rhich 'iN'as 
ordinarily discarded. Further fractionation of this 
extract yielded properdin of purity compara.ble to that 
obtained using the zymosan method of Pillemer et al,. 
(1956). Briefly, the method consisted of (1) concentra-
tion by zinc precipitation, (2) the addition of sodium 
tetrametaphosphate for removal of inert proteins, (3) 
alcohol precipitation or dialysis. 
In addition to alcohol fr,:tctio nation procedures 
for obtaining purified properdin Kent, Toussaint and 
Hook (1957) rr:::ported that t,ht::y were able to precipitate 
properdin by the addition of nine vo:Lumes of 0.0027 N HOI 
to one volume of serum at OOC. The sediment was re·-
moved by centrifugation (200 g, 10 minutes) in the cold. 
The precipitate was not as pure as that previously re· ... 
ported (Pillemer, 1956; Fennell et al., 1957; Spicer, 
et al., 1958) because the procedure precipitated all 
the euglobulins present as well as the properdin fraction. 
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E. Assay of Properdin 
The assay of properdin was originally reported 
by Pillemer et ale (1954). Zymosan (Z) at 15°C complexed 
with properdin (p) to form an insoluble complex (PZ). 
~rhe PZ was capable of inactivating the third component 
of complement (C t 3) at 37°C but not at 15°c. The C'3 
in serum deficient in properdin (HP) was not affected by 
Z at either temperature but was inactivated at 37°C if 
properdin and zymosan both were added. The difference 
of behavior of HP and normal serum was the basis for the 
zymosan assay of properdin. Pillemer ~ ale (1954) 
defined the unit of properdin as " ••• the smallest amount 
of sample that, in the presence of zymosan under controlled 
conditions, reduced the Ct 3 titer of an HP from an initial 
value of 120 units per ml to zero." Briefly the method 
consists of: (1) incubating decreasing amounts of sample 
with a constant amount of HP and zymosan for 60 minutes 
at 37°C, (2) centrifugation of the tubes to remove the 
zymosan particles, and (3) titration of the residu~l 
Ct 3 activity in the supernatant with serum deficient in 
Ct 3 (H3), sheep red blood cells and rabbit hemolysin. 
The amount of hemolysis is compared visually with standards 
prepared by lysing red cells with saponin, and the 50 per 
cent hemolysis end point determined. 
McNall (1957) first reported one of the many mod-
ifications of the zymosan assay procedure. Instead of 
employing human serum for the preparation of RP and H3, 
{"ToNEllI used guinea pig 3erutfl. The advaEbages 1tlere reported 
to be that (1) only 10-20 per cent of :-ruman sera are suit-
able for RP or R3, (2) guinea pig serum has the lowest 
properdin content of any experimental animal, and (3) 
the guinea pig serum has C'3 as its limiting component. 
Furthermore, ri.1cNall used inulin instead of zymosan for 
binding of properdin because it was found that zymosan 
frequently adsorbed out other complement components 
while inulin did not. The amount of hemolysis present 
vras determined by spectrophotometric recording. Hunter 
and Hill (1958) applied HcNall~s procedure to routine 
clinical determinations of properdin levels and reported 
that the procedure was Urelatively simple tl and practical. 
A slight modification in reagent preparation by 
Kent et_ al. (19'57) helped overcome the problem reported 
by Pillemer ~ al. (1956) that the reaction of zymosan 
with properdin of certain animal species was inhibited 
in the pres(::nce of human HP. The problem was solved by 
precipitating the properdin from the test serum as 
euglobulin, then reconstitut,ing the properdin in R3 or 
end piece. nro fold dilutions W8re prepared and 0.:;:,5 
r(~l was added to a :3(~ri.es t" 
;lmount of RP and ·zymosan. After incubation for 60 minutes 
at 37°0, the tubes were centrifuged and the supernatant 
fluid assayed for residual C'3 activity. In addition to 
the above modification, it il\TaS found that addition of 
RP after the PZ complex had formed, instead of simultan-
eously mixing all the reagents, resulted in successful 
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assaying of difficult serae 
Reproducible properdin assay results have been 
reported by Soulier, I\lenache and Larrieu (1957) '\mo 
did not centrifuge the zymosan out of suspension before 
adding the hemolysin and sheep red blood cE;118. The tubes 
were centrifuged just prior to reading the amount of 
hemolysis in the supernatant in a spectrophotometer. 
The possibility that bactericidal and virucidal 
tests could be employed as properdin assay procedures 
a.s well as tannic acid treated human cells was suggested. 
Wardla~r and Pillemer (1956) showed that a relationship 
between bactericidal activity and properdin concentration 
existed. Studies were conducted to determine if a 
bactericidal test for assay of properdin was possible. 
The difficulties involved included (1) preparation of 
an RP completely free of any properdin because 0.01 
units per ml RP was significantly bactericidal, (2) 
the test organism had to be carefully chosen, and (3) 
a means of determining if antibody or bactericidal -
activities of serum other than the properdin system 
might be involved in the reaction. 
The adaptation of a bacteriophage neutralization 
t(~st for the assay of properdin was reported by Van 
Vunakis, Barlow and Levine (1956). Further studies 
(Barlow, Van Vunakis and LeYine, 1958a, 1958b) in-
dicated that the neutralizing activity of human serum 
using T2r+ phage (active against E. coli B) as in-
dicator yielded precise and reproducible results in 
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terms of the 50 per cent neutralizing unit. Evidence 
was presented that the phage-neutralizing activity 
might be a reflection of properdin levels. However, 
Cowan (1958) questioned the phage neutralization tech-
nique for interpretation of properdin levels. Several 
different sera were assayed using T2, T6, and T7 phage 
types. It was proposed that different degrees of 
neutralization would be observed, but if the susceptibility 
of the phages were due to a single substance, the ratio 
of serum titers with the three different phages would 
approximately remain constant from one serum to another. 
If no correlation occurred then it would suggest that the 
neutralizing substance(s) had some degree of specificity 
and would be present in different sera in varying amounts. 
]\To constant ratio was observed by Cowan, and the question 
of the true nature of properdin was discussed. It was 
suggested that properdin may have some degree of specificity 
suggestive of antibody, a hypothesis upheld by Skarnes 
and Watson (1957) and Nelson (195a). 
The use of tannic acid treated human erythrocytes 
for assay of properdin was attempted by Hinz, Abraham 
and Pillemer, (1957). Although purified properdin could 
be reliably assayed, the quantitative measurement of 
properdin in serum was not reproducible. 
Iv1any procedures for assaying properdin are available, 
but no technique is less complex than the others. In 
fact, discrepancies in properdin titers arise "'Then dif-
ferent techniques assay similar serum samples. It may 
'h r< I 0< '"' t:: " 
u e, as ,_: O'V'lan ,,~ 'j;; } sugge sub 
are being mea.sured by the different techniques; nThus, 
one is drairm to the conclusion that either there are 
several different properdins, or that properdin is a 
family of cross""reacting a.ntibodi.es capable of combining 
with zymosan.!! 
~~TERIALS AND METHODS 
I. Animals 
Adult albino mice (Mus musculus) and adult albino rats 
obtained from a local source were employed as test animals 
in radiation experiments. The mice were also used as a 
source of peritoneal phagocytes for the in vitro phagocytosis 
and cytopepsis experiments. 
II. X-irradiation 
X-irradiation of the test animals was accomplished by 
means of a Westinghouse Quadrocondex x-ray machine. The 
technical factors were: 250 KVP; 15 rna; 1.0 mm aluminum and 
0.5 mm aluminum and 0.25 mm copper; target distance, 16 
inches. The mice were irradiated in groups of 10 in a 
cylindrical container with a diameter of 18.5 cm and a height 
of 3.0 cm. The rats were irradiated in groups of 4 in a 
cylindrical container with a diameter of 23 cm and a height 
of 5.5 cm. Guinea pigs were irradiated in groups of 4 in 
a wooden box with dimensions of 8 x 16 x 7.5 inches. All 
animals received total body exposure. The average dose rate 
as measured with a Victoreen r meter was 90 r per minute 
when recorded in the center of a lifelike wax phantom. 
Variation in radiation dose did not exceed 2 r per minute 
when measured in any position in the containers. 
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III. Organisms 
Histoplasma capsulatum, strain G17M, isolated in 1955 
from an accidentally induced superficial skin lesion and 
Candida guilliermondi ATCC 6260 were employed in the in vitro 
phagocytosis and cytopepsis experiments. 
IV. r·1edia 
The H. capsulatum and Q. guilliermondi organisms were 
grown and/or maintained on the following media: 
1) Solid. The organisms were maintained by repeated sub-
culturing on media consisting of tryptose phosphate broth 
(Difco), containing 20 per cent human blood and 2 per cent 
agar. In addition penicillin and streptomycin were added 
to final concentrations of 25 units and 25 ug per ml 
respectively. 
2) Liquid. When organisms were needed for vaccine production 
or metabolically incorporated P-32, the following liquid 
medium was employed: 
Tryptose phosphate broth (Difco) •••• 29.4 gm 
Yeast extract....................... 4.0 gm 
r,,'Taltose ••••••••••••••••••••••••••••• 10.0 gm 
Cystine............................. 0.5 gm 
Distilled H20 ••••••••••••••••••••• 1000 ml 
3) Phagocyte buffer solution. The macrophage maintenance 
fluid employed in the experiments was composed of the 
following: 
~. Earlo'3 ~alanced Sa~t Sohlticn t3SS) 
Phenol red •• G •• O •• ooo.oo ••••••••• o. 0.02 gm 
'j"T9.C 1 • 0 0 ••••••••••• 0 • 0 • 0 •• 0 • 0 0 •••• 0 • 6.80 gm 
T,,,,..., .~ 
,~)..;_ •••••••••••••• 00000.00 ••• 0 •••••• 0 0 11-0 gm 
'" r c: (' • 7'U n ; 'If:, ' ... ' ,) I In,.. • ••• 0 0 0 0 0 0 0 •••• 0 ••••••• 0 • 
t+ 2 
0 0 20 gm 
'T ~"F('\ ."- n ;. a h-' U 4 J \ 2 ... : •• 0 0 0 • 0 •••••• 0 •••• 0 • 0 •••• 0.14 gm 
Glucose ••••••••••• 0 ••• 0 ••••••••• 000 1.00 gm 
CaC]~ ••••••• 00 •••••• 0 •••••••••••••• 0.20 gm 
t::., 
Distilled H20 •••••• 0000 ••••••••• 1000 ml 
The CaC12 was added last to avoid precipitate 
formation. This stock solution was made up 10 times 
concentrated and sterilized in the autoclave for 15 
minutes at 15 pounds pressure. Working solutions 
were obtained by diluting the stock solution l~lO 
with sterile distil1~?d water on the day of US(~. 
b.ft Bicarbonate Solution 
••••• 000 ••••••••••••• 0.0.0 •• 50.0 gm 
Phenol red •••••••••••• 0 ••••••••• 0. 0.02 gm 
Distilled H20 •• 0 ••••••• 00.o ••••• ~lOOO ml 
This solution 'was s'tt;r.ilized in the autoclave for 
15 minutes at 15 pounds pressure. 
The diluted Ea.~le \I s BSS vIas prepared and m:i xed with 
penicillin and streptomycin (100 units and 100 ug per reI of 
each antibiotic respeotively). The pH of the solution was 
adjusted to 7.2 - 7.4 by the addition of NaHC03 (5 per cent 
solution) • 
The experiment 
killed yeast phase £I. • .QEJ?sulatum vaccine prepared in the 
following manner~ A 1.0 ml bro'th ion of yeast phase 
organisms was added 'to 800 ml of liquid culture medium con· ... 
tained in a low-form culture flask of 2500 ml capacity. The 
flask 1lJ'as incubated 37°C vlfith a,dequate agitation to insure 
maximum g:rollvth 1flri thin 3 to 7 days. After maximal growth was 
obtained, formalin vias added to a final. concentration of 0.5 
per cent -' and the flasks ~Tere re-incabated overnight. As 
demonstrated by cult.ure on antibiot containing blood agar 
media, the procedure had inactivat the yeast phase organisms. 
The cells were concentrated and V\rash\::~d with saline by cen-
trifugation procedures. After th(j final wash, the cells 
were resuspended to a concentration of 107 organisms pe~ 
ml with saline and used as vaccine. 
The mice were immunized by intraperitoneal injection of 
0.5 ml of the formalin-killed suspension. The injection 
schedule was 3 injections spaced on 
immunized by intravenous injection 
apa.rt. Rabbits \rv8Y"e 
0.25 m1 of the vaccirH:'. 
injection schedule was 3 inject ions per W8elc and a total 
of 12 injections. 
VI. Pha.gocytes 
Peri toneal e:x:udation v':;PtS induced in normal a.nd 
munized mice by intrap~;~Aitonea.l injection of 1 ml of 0.002 
per cent (20 ug) glJcogen~saline solution. Forty-eight 
hours lat er, vvhen mcijority of peritoneal c 
IJopulation 'were macrophages the mi.ce lf1fere decapttated. 
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The peritoneal cavities 't'lere: 1~Ia.sh(.:;d vrith 5 m1 of Earle? s 
BSS and the washings and cells vv'ere collected in one pool in 
silicone-coated tubes 0 The ce.1::"s 'Wer(~ concentrated by low 
speed centrifugation (150·-200 g ';, HW'ashed three times in 
Earle's I3SS, and resuspended in a small kno'tt'm volume of 
Earle's BSS. An aliquot of cells was counted in a hemocyto-
meter chamber, and the desired concentration of the suspension 
was obtained by dilution. The cells were allowed to attach 
to the bottom of 50 ml glass stoppered flasks. Sufficient 
phagocyte maintenance fluid vlas added to maintain the 
proper pH environment. Attachment of the cells was allowed 
to proceed for 5 hours at 37°0. 
Another procedure involved the attachment of phagocytes 
to cover slips placed in steel counting planchets for cor-
relation studies between radioactivity counts and micro-
scopic evidence of phagocytosis and cytopepsis. The details 
of this procedure are given on the section of phagocytosis 
and digestion quantitation. 
VII. Serum 
Serum was obtained from normal and immunized rabbits 
by cardiac puncture after ether anesthesiao Afte~ the 
bleeding, the animals were given intravenous solutions of 
commercially obtainable glucose-salt solution.:r.c: This pro-
cedure enabled 'the animals to overcome the hemorrhagic shock 
~:~This solution was obtained from Allied Pharmacal Company, 
Inc., Centerville, Utah, and marketed under the trade name 
of 1'·1ultisalo 
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and remain viable. The antibody titer the serum was 
determined by complement fixation (r,Iicro .... Kolrner) using a 
cell-free extract preparation as antigen. 
~Vhole bovine blood was obtained from a local slaughter-
house. The serum was recovered by centrifugation and stored 
at _20°C until used. 
Healthy adult guinea pigs were bled by cardiac puncture 
under ether anesthesia. The blood was allowed to clot and 
the serum recovered by centrifugation. The residual cells 
and bacteria were removed by passing the serum through a 
Seitz filter under positive pressure. The whole complement 
titer was unchanged as a result of the filtration process. 
The bacteria-free serum was sealed in glass ampules and 
stored at -650 e until used. 
The whole Ct titer of the serum from normal and 
immunized rabbits and from normal guinea pigs was determined 
by the Micro-Kolmer technique (Kolmer, Spaulding and Robinson, 
1951). 
The properdin content of the rabbit serum was determined 
by the zymosan assay procedure of Pillemer ~~. (1956). 
VIII. Zymosan Adsorption 
The rabbit serum used in certain experimental procedures 
was absorbed with svmosan to deplete it of properdin. The 
serum was placed in a tube and equilibrated to 150± 10e in 
a water bath. For each ml of s'erum, 0.3 ml of a 15 mgrn 
per nl zymosan suspension (Pi11emer et ale 1956) was added. 
The mixture was maintained at 150± 10C for 75 minutes with 
occasional mixing to resuspend the zymosan. After the incuba-
tion period the mixture was centrifuged at 1000 g for 60 
minutes in a refrigerated centrifuge. The supernate was 
assayed for properdin, complement and antibody titer. In 
all cases, the properdin content was less than 1 unit per 
ml, the whole complement titer did not decrease appreciably, 
and the antibody titer remained the same. 
IX. Properdin 
The purified human properdin used in the experiments was 
obtained from the late Dr. L. Pi11emer, Western Reserve 
University, and from Dr. B. E. Sanders, Merck Institute of 
Therapeutic Research. The preparations were assayed in 
this laboratory and confirmation of the original titers 
was obtained. Partially purified bovine properdin solutions 
prepared as described in the experimental results were also 
employed. 
x. Labeling of Organisms 
Yeast phase cells used in these experiments were 
labeled with phosphorus-32 (P-32) by employing metabolic 
incorporation techniques. The cells were grown in liquid 
culture medium containing between 10 and 20 microcuries of 
P-32 per m1 (Hill, 1958). The cultures were agitated 
continuously for 3 days at 370 0. At the end of the growth 
period, the cells were washed four times with sterile saline 
and transferred to another flask containing sterile 0.5 
per cent glucose solution. The cells ,,,,ere re-incubated at 
37°C with shaking for one hour so that the yeast phase 
organisms could rid themselves of the easily exchanged P-32 
and stabilize the remaining isotope more firmly 'tAlithin the 
cell. Cells treated i.n this manner showed a range of specific 
activity of from 800 to 1500 counts per minute per 106 cells 
which is comparable to results obtained by 1-li11 (1958). 
XI. Phagocytosis and Digestion Quantitation 
Radioactivity measurements and microscopic examination 
were two techniques employed for quantitating phagocytosis 
and digestion of yeast phase H. capsulatum cells by normal 
and uimmune" mouse phagocytes. The radioactivity measure-
ment technique is as fol1ows~ 
A constant number of P-32 labeled cells were added to a 
50 ml glass stoppered flask which contained phagocytes attached 
to the bottom and overlayed '{lIi th maintenance fluid (20 ml). 
The various serum factors to be tested were added concomitantly 
with the addition of the P-32 labeled yeast phase organisms. 
The reaction flask was incubated at 37°C on a shaker. The 
oscillation rate was 25-)0 cycles per minute with an amplitude 
of 2.5 em. At various time intervals an aliquot of the 
supernatant fluid was removed and transferred to a steel 
counting planchet. 
Phagocytosis and cytopepsis of labeled organisms by 
phagocytes was also correlated microscopically employing a 
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technique modified from Hill (1958). A predetermined number 
of washed phagocytes contained in 1.5 ml of maintenance 
fluid was added to siliconed, steel counting p1anchets which 
contained 22 mm round cover slips. The planchets were en-
closed in petri dishes. The cell suspension 1t,TaS overlayed 
l!Jith 1 ml of sterile mineral oil (Braun-Knecht-Heimann, No. 9)0 
I';lineral oil was added to prevent C02 loss from the small 
volume of fluid. The phagocytes were allowed to attach to 
the cover slips for 5 hours at 370 C. The labeled organisms 
were added with a sterile syringe (0.1 ml). At suitable 
time intervals, a planchet was removed and gently agitated 
to suspend the non-phagocytized labeled particulate matter. 
The cover slip was removed, thoroughly rinsed in buffer and 
placed in absolute methanol to fix the phagocytes. The 
radioactivity of the cover slip was determined (phagocytosis), 
then the cells were stained with Giemsa's stain. The degree 
of phagocytosis and digestion observed microscopically was 
then correlated with the radioactivity counts. 
Other experiments were conducted to determine the number 
of viable yeast phase organism at various time intervals 
when exposed to phagocytes from normal and immunized mice. 
Aliquots of the supernate fluid from the reaction flask were 
transferred to antibiotic containing blood agar medium and 
spread over the surface with the aid of a bent glass rod. 
The petri dishes were sealed with parafilm and incubated at 
370 C for 7-14 days. Colony counts were done employing the 
Quebec colony counter. 
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The supernatant fluid samples were transferred to counting 
planchets, evenly distributed over the bottom surface, and 
allowed to air dry. FollofN'ing t.his procedu,re, the sample-
containing planchet was placed in a dry heat oven at a 
o temperature of 90 C for 2 hours in order to destroy any 
viable rr. capsulatum organisms present and avoid contamina-
tion of the radioactive isotope counting equipment. The 
samples were counted in a Nuclear Chicago Gas Flow isotope 
counter (Model D47), and the relative activity of the 
samples was determined. All samples were counted during the 
same day, therefore no decay correction factor was applied 
to the counts obtained. The efficiency of the equipment was 
periodically checked with a carbon-14 standard. 
The counting error in <:tIl radioactive measurements '1ITas 
calculated to be 194 per cent. 
XI • Other l\Iaterial,s a,nd r,1ethods 
The foregoing methods and materials are considered 
standard. T"Iodifications of the procedures are specified ::.n 
the section on experimental results and have been placed 
there for the purposes of continuity. 
..,. t- . d d"· ra0.::.a 10n"".ln ue (~ lnJUry 
es susc 'ty of' the host. 
to infection. Pr"op::·~rdin has been ~eported (Ross et .9~:~o, 
labor,s.tory animal.s agai l:.st 
:tnjury. In th(), experimental results t;o 
be reported, the ro of prcperd hest resistanoe 
mechanisms "(q(:1.3 irnrGstigat 0 was proposed that if pro-
perdin was found to be effective protecting animals against 
the effec G of ~~hole body ionizing x· .. irrad ion, this pro .... 
tection could related to the enb.ancement of the act.ivities 
of phag;ocytes by prop'9rdin. 
PAIriIALLY :PURIFIED 
FROPEHDIl"J BY :ITIANOL FRACTIONATION 
A procedure for the isolation and cone ion of 
properdin subs·tance was des(jribed by Pil10mer a+,. (1956). 
'2he protocol in'\TO 
.ion uno,er condi i~}l1s 0 use of 
the zymos:.~,n ,)crption tec;h:niquE:' y~elded final pro-
sine€; zymosan 
io:n') varied in aotivity. 
r .', r, 
\ ~;.) reported properdin is found 
in serum F'rac:tion III using separa.tion procedurt~ desoribed 
by D 7) used f··lethod 6 
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the total properdin activity of plasma was recovered in a 
subfraction of Fraction I, and the remaining activity appeared 
in Fraction III. Linder (1957) has shown that the majority 
of the properdin activity of human serum resides in the gamma 
globulin eluate when the serum constituents are separated 
e1ectrophoretica11y. 
Experiments designed to determine the value of properdin 
as a therapeutic agent following the exposure of animals to 
whole body x-irradiation made necessary the preparation of 
properdin solutions of high activity per unit volume in order 
that adequate concentrations of material could be administered 
intravenously or intraperitonea11y without causing physio-
logical stress in mice and rats. A Cohn ethanol fractionation 
(modified Method 6) procedure was employed to obtain partially 
purified properdin solutions without using the variable and 
costly zymosan. The results of a direct ethanol fractiona-
tion procedure are presented in this section. 
~fuole blood of healthy adult cows was collected in 
sodium dichromate-sulfuric acid cleaned glass receptacles and 
allowed to stand at room temperature for 2 hourse The clots 
were then rimmed and the blood stored overnight at 2oC. The 
serum was separated by centrifugation at high speed in a 
refrigerated centrifuge. The clear serum was used immediately 
in the fractionation procedure. 
For each liter of serum the follOwing ethanol buffer 
solution was prepared: 
601 ml of 53.3 per cent ethyl alcohol at -50 C 
0.$$ ml of 10 M acetic acid at 250 C 
2.30 ml of 95 per cent ethyl alcohol at -SoC 
temperature and thoroughly mixed together. entire 
mixture 11'las allo1l:ed to equilibrate at ""'5°C before addit 
to the serum. 
A pH 7.1." barbital buffer was prepared according to 
the direct ions of ICabat and l'!Iayer (1948). 
A constant temperature bath was prepared in the fol .... 
lowing manner: A double jacketed stainless steel container 
was constructed Q smaller inner compartment contained a 
solution of sodium chloride with a freezing point depression 
of -5°C to .... 6°C. The larger outer compartment aincd the 
freezing mixture of calcium chloride and ice. 
The fractionation procedure was as follows: The glass 
container holding the clear bovine serum was placed into the 
NaCl solution. The serum was stirred slowly with a mechanical 
agitator to hasten equilibrium conditions and prevent ice 
crystal formation. lflhen the temper2.ture of the serum w'as OoC, 
the precooled (-5°C) ethanol buffer mixture was El,ddedQ 'rhe 
rate of addition through a capillary jet was 5-6 ml per minute. 
The overall addition time per liter of serum was about 2 hours. 
The entire mixture was adequately stirred during the addition 
of the ethanol buffer mixture in order to prevent high ethanol 
concentrations near the jet tip which could cause irreversible 
protein changes. The final concentration of ethanol was 20 
per c(~nt v/v. After addition of the ethanol buffer solution 
the mixture 1"laS continually stirred for another 60 minutes tol 
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C are was exerc:i s to keep s miXGure at a 
tempera ture of - 50t 0.5° C • The result. i n1s pr8c i pi 
centrifuged out at high sp€'ed in a refrig'2rated centrifuge 
(OoC). The supernate was discarded, and the centrifuge 
tubes were inverted 10 minutes in gerator to drain 
the excess fluid. 
The precipitate V'ira.s redissol-v-ed in 7.h barbital buf-
fer, (250 ml buffer/liter of original serum used). The re-
dissolved protein fraction was transferred to a filtering 
flask, and negative pressure was applied to remove the 
residual alcohol. This opera'tion was carried out at room 
temperature. The protein solution was cooled to OOC for 24 
hours during which time a precipitate appeared. The mixture 
was centrifuged and the residue collected. The supernate 
was discarded. The residue was treated with pH 7.4 barbital 
buffer (3 ml buffer per ml of residue). Suspension of the 
residue was obtained by gentle agitation at room temperature. 
The final product was a stable turbi.d c3US1)(H1Sion and 'tita:::; 
stored at oOe. 
The titers of the properdin mixtures at val""ious 2>teps 
in the isolation are shown in Table ~~. 
It is seen that considerable increase in activity, on 
a volume basis was achievedJl i.e., from 15 to 100 units per 
mI. However, the ing procedure was carried out at a net 
loss, i.e., from 15000 units to 6000 units or a net recovery 
of about 40 per cent. The value of the procedure derives 
from the increased concentration per unit volume. 
Anticomplementary titers of the products were determined 
TABLE II 
PROPERDIN ACTIVITY OF VARIOUS FRACTIONS 
OBTAINED DURING ISOLATION PROCEDURE 
Hater-ial Amount Properdin):~ Hg N (ml) ._~_units/ml p~ml,_ 
Bovine serum 1000 15 18.7 
! 
Redissolved ethanol 
rprecipitation fraction 250 100-200 2705 
! Supernate fr0m cold 
separation centrifugation 235 2-4 12.7 
Hesidue from cold 
~)E~paratj_on centrifugation 15 400 37.6 
1 60 Final suspension 100 9.4 
edure of Pil.1emer et. s.:~~o (1956) 0 
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r 
Normal bovine serum 
First precipitation 
Second precipitation 
Figure I. El.ectrophoretic pattern of partially purif'ied 
properdin prepared by T./[ethod 6 modification of Cohn ethanol 
procedure. 
in conjunction with the properdin assays and in each case the 
product was shown to be non-anticomplementary. The final 
product had paper electrophoretic characteristics of 
gamma globulin as shown in Figure 1. 
II. EFFECT OF PROPERDIN ON 
WHOLE BODY IRRADIATED MICE AND RATS 
The parenteral administration of properdin of hetero-
logous origin into rats and mice has been reported to protect 
significantly against LDIOO/30 day and LD IOO/ 6 day doses of 
whole body x-irradiation (Ross ~ al., 1955; Ross, 1956). 
The degree of protection was reported to be dependent on the 
dose, route and time of administration of properdin. Ross 
(1956) observed that mice exposed to 600 r and treated with 
50 units of partially purified bovine properdin administered 
intravenously on the fifth post-irradiation day showed a four-
fold greater 30 day survival rate than the untreated controls. 
However, mice treated with properdin on the second, third, 
fourth, seventh or tenth post-irradiation days showed similar 
or accelerated death rates as compared to the controls. In 
order to further assess the role of properdin in protection 
of animals against the effects of whole body x-irradiation, 
experiments were conducted to determine the value of properdin 
as a therapeutic agent. 
The properdin solutions were prepared from fresh 
bovine serum according to the zymosan adsorption technique 
of Pillemer et al. (1956), and also by a modified Cohn 
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ethanol fractionation procedure. In addition, purified human 
properdin was used in the experiments. rrhe titers of the 
partially purified properdin (Ppp) solutions and the human 
properdin (HP) were determined by the zymosan assay techn:i.queo~:::: 
The route and time of administration of the properdin solutions 
is given in each experimental design. 
A. Effect of iDtravenous injection of J;2r,operdin J-n 
x-irradiated~. 1',!1ice were exposed to a single 550 r total 
body dose of x-irradiation and randomly divided into groups. 
Animals of the first group of 11 mice were injected intra-
venously with 50 units of PPP on the first post-irradiation 
day. The next three groups of 11 mice each were treated with 
50 units of intravenously administered PPP on the third, 
fifth and seventh post-irradiation days, respectively. The 
fifth group of 40 mice was used as untreated controls. The 
mortality curves following this irradiation and treatment 
procedure are shown in Figure 2. It is seen ~hAt the 
intravenous injection of PPP did not afford any protection to 
the x-irradiated mice regardless of the time of administrationo 
However, there appe'ared to be a trend toward delayed mortality 
if treatment was initiated early following total body x-irrG.di .... 
ation. 
In another experiment, the .first group of 10 mice each 
receiverl. 50 units of HP intravenously on the first post-
*The original RP and R3 assay reagents were kindly supplied 
by the late Dr. Louis Pillemer and ~~. Earl W. Todd of the 
Insti tute of Pathology, \vestern Reserve University, Cleve-
l~nd, Ohio. Portions of the supplied reagents were used to 
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Figure 2. I'.1ortality of adult albino mice treated 
intravenously with 50 units of partially purified bovine 
properdin (pPP) following 550 r total body x-irradiation. 
TABLE III 
SURVIVAL OF ADULT ALBINO MICE TREATED INTRAVENOUSLY 
WI 50 UTIJITS OF PUHIFIED HUMAN PROPERDIN (HP) 
FOLLOWI 550 r TOTAL BODY X-IRRADIATION 
Treatment Number 














* PID, post,irradiation day. 
6.0 
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irradiation day following a single exposure to 550 r of total 
body x-irradiation. A similar number of mice received the 
same treatment on the third post-irradiation day and a third 
group of 10 mice each received 50 units of HP intravenously 
on the fifth post-irradiation day. A fourth group of 33 mice 
were used as untreated controls. The median survival days 
are shown in Table 3. It is seen that post-irradiation 
treatment with 50 units of HP administered intravenously did 
not yield any protection to the whole body x-irradiated mice 
regardless of the time of administration. 
B. Effect of intraperitoneally injected properdin in 
x-irradiated mice. It is difficult to obtain properdin with 
high activity per unit volume. In order to increase the 
host systemic concentration of properdin, it was suggested 
that the intraperitoneal injection of large doses of properdin 
solution would enable the host to absorb more properdin than 
could be administered by the intravenous route. This i.ncreased 
level of properdin might then be effective in protecting 
against the effects of whole body x-irradiation. To test this 
hypothesis, mice were subjected to 600 r of whole body 
x-irradiation and randomly separated into 5 groups. The 
first group of 20 mice received 200 units of PPP intraperiton-
eally on the third post-irradiation day; the second and third 
groups of mice (20 mice per group) each received 200 units 
of PPP injected intraperitoneally on the fifth and seventh 
post-irradiation days respectively. The fourth group of 20 
mice received a total of 600 units of PPP administered intra-
peritoneally at a dosage of 200 units per day given on the 
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Time (days post-irradiation) 
Figure 3 0 ~.,1ortality of adult albino mice treated intra-
peritoneally with partially purified bovine properdin (PPP) 
following 600 r total body x-irradiationo 
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third, fourth and fifth post-irradiat 3. The 25 mice 
of the fifth group were used as controls. The mortality 
curves of this irradiation and treatment experiment are shoWl1 
in Figllre 3. It is seen from the results that properdjn -Nas 
not effective as a therapeutic agent against the effects of 
whole body x-irradiation even in concentrations as high as 600 
units when given by the intraperi.tonea.1 route, regardless of 
the time of administration. 
C. Effect of complement ,i..!1J§cted concomitantly with 
,Properdin in x-irradiated mice. Various investigators have 
reported that mouse serum i.5 deficient in complement components 
(Brown, 1943; Rice and ero·vlrson, 1950; Pillemer, 1956). The 
lack of bactericidal act,iv1ty of mouse serum repcrted by Marcus 
et ale (1954) could be explained as a result of deficient 
complement components. Since the properdin system has been 
reported by Pillemer at, ale (1954) to requi.re the four com-
ponents of complement and Mg++ for its activation, the failure 
of properdin to prot0ct mics against th.e effects of whole· ... 
body x-irradiation might be explained on this basis. An ex-
periment was carried out in order to determine if the properdin 
system could be activated in vivo in the mouse by concomitant 
inject ion of guinea. pig complement vV'i th properdin. Groups of 
mice were exposed to 500 r of total body x-irradiation and 
treated with 200 units of PPP and 33 units of guinea pig 
complement (GPCi'). The mixture was administered intraperi-
toneally rather than intravenously since a total volume of 1.1 
ml was injected. The resuit.s are ShO't\l1 in Table IV. It is 
seen that x-irradiatE!d mice w(;'re not protected even though all 
TABLE III 
SURVIVAL OF ADULT ALBI I\'1ICE THEATED INTHllPERITONEALLY 
WITH 200 UNITS OF PA1~TIALLY PURIFIED BOVIT-lE PROPERDIIJ 
(PPP) AND 33 UNITS OF GUINEA G GOT,:IPLEMENT (GPC') 
FOLLOWING 550 r IrOTAL BODY X-IRRADIATION 
Treatment Number 
Treatment daI of mice Median survival. AC!Y 
PPP + GPC' 1 PID):~ 10 l.,..O 
GPC' 1 ~q 5 7.0 
PPP + GPC ~ 3 ti 10 4.5 
GPC' 3 tv 5 15.0 
PPP + GPe! 5 it 10 .5.0 
G':J P' 5 n 5 4.5 
PPF + GPe '( 7 !W 10 4 r' 
-. -....' 
7 u 5 5.0 
Control 20 6.5 
Ill"" -~ 
':' PID, st-irradiation day. 
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day of the treated nice was, in 
compared to the control group. 
the concentrations employed. 
h C. 
D • ,.sfl~ect of: ,;~~;"':-:";"~::' ... :~~~""=.~,:::'-=:";!..7.:~.;;.::~;;;:,,,r,. 
~""irracliated rats. rrh:::: 
erum inactivates guinea 
failure of properdin to 
as 
rlot i.n 
cd mice might b" 
explained on this basi:::. It ('as be[.~,n i::d us and 
Donaldson, 1953; Donaldson and MarcuE, 1954) that x-irradiation 
not a~fect rabbit complement tit0rs. Furthermore Ross 
(1956) rr:ported ,that cornp12(JJent component titers of thf:;'l rC.tt 
were not affacted by x-irradiation. Therefore in subsequent 
experiments rats were used. 
Groups of rats 'tr,rE';rb 3ttbjectE:d tc' r of ,,,,,ho body 
x-irradi8.tion a.nd randomly div1ded inca 7 gT"OUps. The first 
group of 15 rats receivE;d 200 units of PPF :injected intrEl.pert·A 
toneal1y ~n the third post~irradiation • The next two 
grou of 15 rats per group each recc 208 tlni ts of 
intro:::}--:;t';'ritoneal1y on thE-) fjfth and sI3'Tf:.:nth i)o,st .... irradiation 
day s, :r.'{;:spectlvely. The fOl'i:-'t:r~. group of 15 rat s rec ei"f,t~?d a 
total of 1000 ucits of PPP intraperitoneally a dosar9 
r~te of 2(0 'i..H1its p(~r day for 5 cons,;;\~utive days starting 
with tb.t2: ird post .... irradiation da'y. fifth group of 15 
r;:l,t~J rf\(~~-i. a total c? 5JC un:i~;~ of administered intra ..... 
peritoneally a rate of 100 units par day for 5 consecutive 
days st ing l\yith the 'third post-irradiaticH1 day. The sixth 
group of 14 rats received a total of 250 units of PPP intra-
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peritoneally injected at a rate of 50 units per day for 5 
consecutive days commencing with the third post-irradiation 
day. The seventh group of 20 rats was untreated and held as 
controls. The results of this experiment are shown in Table 
V. It is seen that properdin did not protect rats from the 
effects of whole body x-irradiation, e'Ven in doses as high 
as 1000 units when administered by the intraperitoneal route. 
The median survival day of the groups receiving multiple 
injections is seen to be similar to or slightly accelerated 
compared to the control group and groups receiving a single 
treatment. It is also seen that a trend toward delayed mortal-
ity appears to occur if a single injection of properdin is 
given to rats early in treatment following whole body 
x-irradiation. 
III. STUDIES WITH CELL-FREE SPLEEN EXTRACTS 
It is a current hypothesis that the effectiveness of 
post-irradiation treatment with hematopoietic containing 
tissues is a function of "cellular repopulation tt and/or 
"transitory activity" of the injected cells pending recovery 
of recipient marrow rather than any elusive humoral factor 
which stimulates recovery. Experimental evidence has demon-
strated the replacement of circulating erythrocytes, platelets 
and leukocytes in x-irradiated recipients by parenterally 
introduced cellular components from non-irradiated donors 
(Ford et al., 1957; Nowell et al., 1957). Jacobson (1956) 
has reported that at least 50,000 spleen cells are required 
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TABLE V 
SURVIVAL OF ADULT ALBINO RATS TREATED INTRAPERITONEALLY 
WITH PARTIALLY PURIFIED BOVINE PROPERDIN (PPP) 
FOLLOWING 720 r TOTAL BODY X-IRRADIATION 
Treatment Treatment Number 
PPP day of rats Median survival day 
200 units 3 PID::o:~ 15 15.0 
200 n 5 n 15 6.5 
200 n 7 It 15 6.5 
200 n 3,4,5,6,7 " 15 6.0 
100 
" " 
fI 15 6.5 
50 tI It " 14 6.5 
Control 20 7.5 
::0::: PID, post-irradiation day. 
co enhance survival of irrad m.1.l~. ()n other hand, 
Ellinger (1956, 1957) has report prot~ctjon of mice and 
guinea pigs against deat.h follo1,\"ing ,:.:!xpof.n .. rr'e co 'trfuole body 
x-irradiation by injection cell-free mcuse spleen extract. 
The results of experiments conducted to determine the value 
of cell-free mouse spleen extracts employed as a protective 
agent for mice and guinea pigs exposed to '~101e body 
x-irradiation are presented in this section. It was pro-
posed that if protection ,,,,as observed, then the effects might 
be due to properdin. 
The cell-free extract was prepared in the following 
manner. Spleens from 350 normal albino mice of mixed gender, 
age and size were removed following ether anesthesia. The 
spleens were placed in a precooled mechanical blender con-
taining 350 ml of 0.15 M saline and homogenized in t\v"O peri.ods 
of one minute each with cooling in between. The homogenate 
was alternately frozen and thawed three times for maximum 
cellular disruption. The mixture was then placed in a 
refrigerator for 24 hours after which it '(I'las centrifuged in 
a refrigerated contrifuge a.t high spe t3d. The supernate 'f/V'as 
passed through several layers of h1hatman No. 1 filter paper 
in a Duchner funnel under light negative pressure. r"Iicro-
scopic examination of numerous fields of the resulting 
filtrate failed to show any intact cells, therefore the extract 
was assumed to be cell-free. The extract was then lyophilized 
and stored at -20°C. ~Phe entire procedure was conducted 
under aseptic conditions at low temperatures. 
Forty-five mice similar to thOSt~ used for the prepara.-
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t ion of the splenic extract V,Tere e.xpo'3E;d to 600 r total body 
x-irradiation. The dosage corresponded a LDIOO/IO days. 
The mice were randomly divided into t1~ groups of 20 and 25; 
the larger group served as controls. The ~yophilized spleen 
extract was resuspended in 0.15 r,'I sterile saline to give a 
concentration corresponding to four spleens per mI. This 
extract was injected intraperitoneally, 0.1 ml immediately 
following exposure the day of irradiation .and 0.6 ml admin-
istered at a dose of 0.2 ml per day orl the first, second and 
third post-irradiatlon days for a sum total of 0.7 mI. 
Thirty-three guinea pigs of mixed gender, each weighing 
about 600 g were exposed to a total body dose of 450 r. The 
dosage corresponded to a LDS5/10 days under these conditions. 
These a.nimals were randomly divided into two groups of 20 
and 13 each, the smaller group serving as controls. The 
treated animals were injected intramuscularly with 0.5 ml of 
the spleen extract immediately after irradiation and 2.0 ml 
was administered at a dose of 0.5 ml per day given on the 
first, second, third, and fourth post-irradiation days for 
a sum total of 2.5 mI. 
The results of the experiments are shown in Figure 4. 
It can be seen that post-irradiation treatment of whole body 
x-irradiated mice and. guinea pigs with cell-free spleen 
extracts under the conditions noted, did not result in pro-
tection against post-irradiati.on mortality. In fact, treated 
animals died at an accelerated rate when compared to the 
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Figure 40 Mortality of adult albino mice treated intra-
peritoneally and guinea pigs treated intramuscularly with 
cell-free spleen extract following 600 rand 450 r total body 
x-irradiation, respectively. 
72 
• EFFECT OF COMPLEI'fIENT AND PHOPERDIN ON VITRO 
PHAGOCYTIC AND CYTOPEPI'IC ACTIVITIES OF NORMAL 
AND nIlVIT,:UNE" PHAGOCYTES 
Cellular as well as humoral factors must be considered 
in any investigation designed to study the role of various 
factors in host resistance to infectious diseaseso It is 
well established that antibacterial antibodies (bacterio-
tropins) possess the properties of thermostability and speci-
fic opsonizing capacity. Evidence has been provided by Cowie 
and Chapin (1907), Dean (1907), and Egger (1908) that the 
effect of thermostable opsonin is increased by the addition 
of complemento Further, the rate of phagocytosis of heat-
killed encapsulated pneumococci has been sho1NTl by Ward and 
Enders (1933) to be increased in the presence of antibody 
and complement as compared to the effect of antibody alone o 
The hypothesis can be derived from this work that the thermo-
labile factor (complement) did not increase the absolute 
capacity of antibody to promote phagocytosis, but that the 
increased reaction rate observed in the presence of anti-
body and complement was a function of an increase in the 
veloci.ty with which the organisms were prepared for inges-
tion. 
The process by which the host's cellular defenses are 
able to destroy or inactivate parenterally introduced foreign 
particulate matter can be divided into two stages: (1) 
ingestion or phagocytosis and, (2) intracellular digestion or 
cytopepsis o Antibody and complement have been shown to 
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promote phagocytosis. The hypothesis examined was that anti-
body and/or complement are also necessary to promote optimal 
cytopeptic activity of phagocyteso The contributing role of 
the recently discovered serum protein, properdin, (Pillemer 
et al., 1954) in phagocytosis and cytopeptic action of 
phagocytes was also investigated. 
This section of the thesis is concerned with results 
relevant to the problem of quantitating the effects of 
various substances on the ingestive and digestive activities 
of mouse peritoneal phagocytes by isotope counting techniques 
employed in an in vitro system. 
A. Isotope technigueo Peritoneal exudate cells were 
allowed to attach to the bottom of glass stoppered flasks, 
and a known number of P-32 labeled C. guilliermondi cells were 
added. The supernatant fluid was sampled at various time 
intervals and transferred to a counting plancheto At the 
same time, using the samples of the same phagocyte suspension, 
counts were obtained from cover slip preparations which had 
attached phagocytes exposed to P-32 labeled Co guilliermondi 
cellso As shown in Figure 5, the counts obtained are inversely 
related. That is, the activity of the cover slip preparations 
increased initially while the supernatant fluid samples de-
creased. Microscopic examination of stained cover slip 
preparations showed that the yeast cells were ingested by 
phagocytes and not merely attached to the cover slip itself. 
Therefore, decreasing activity of supernatant fluid aliquots 
strongly suggest that phagocytosis is occurringo 
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Figure 50 Phosphorus-32 activity of cover slip prepara-
tions and supernatant fluid of normal mouse phagocytes after 
exposure to labeled Candida guilliermondi. 
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Bo Determination of optimal complement ~ concentration. 
In order to determine the concentration of guinea pig com-
plement that would be optimal for phagocytosis of ~. 
guilliermondi by mouse phagocytes, the following experiment 
was conducted. Normal mouse peritoneal phagocytes were 
allowed to attach to the bottom of 50 ml glass-stoppered 
flasks. Three different concentrations of guinea pig C' 
(133, 66, and 16 units per ml of buffer) were added with the 
P-32 labeled yeast cells o The supernatant was sampled as 
described previously and the radioactivity determined. It 
is seen in Figure 6 that C' concentrations of 133 and 66 
units per ml of buffer closely paralleled each other in the 
rate of removal of the yeast from the supernatant while C' 
concentrations of 16 units per ml appear to be slower. In 
terms of serum concentrations, 133, 66 and 16 C' units per 
ml of buffer corresponded to 25, 12.5 and 205 per cent and 
showed a phagocytic rate comparable to 205 per cent (16 C' 
units per ml buffer) of unheated guinea pig complement. As 
expected, the phagocytic rate in the absence of serum compo-
nents was considerably slower. The complement concentration 
chosen for future experiments was 66 units of C' per ml of 
buffer. If the guinea pig serum had a whole C' titer of 500 
units per ml, then a 1205 per cent serum concentration was 
used. 
The whole C' titer of the different preparations were 
determined at various time intervals to see the extent of in-
activation of the complement by the different components of 
the in vitro phagocytosis systemo It is seen in Table VI 
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Figure 6. Effect of varying concentrations of guinea 
pig complement (C') on phagocytosis of P-32 labeled Candida 
guilliermondi by normal mouse peritoneal phagocytes o 
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TABLE 
EFFECT OF COTI1PONENTS OF IN VITRO PHAGOCYTOSIS EXPERIMENTS 
ON INACTIVATION OF GUINEA PIG COMPLEMENT (GPC') 
Cf units/m1 
Components 
8 16 O"~ 2 4 24 ','
25% g.p. serum + phagocytes 
+ Candida 133 133 133 133 133 100 
1205% n If n 66 66 66 66 66 50 
2.5% If 17 n 16 16 16 13 10 d u 
2. heated gop~' ,serum + 
phagocytes + Candida 0 
25% gop. serum + Candida 133 133 133 133 133 100 
25-1 II.? n " + phagocytes 133 133 133 133 133 100 
~:( time in hours. 
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in guinea pig serum concentrations of 25 and 1205 per cent. 
However, guinea pig serum concentrations of 205 per cent 
show a loss of 50 per cent C' activity at the end of 24 
hours. It is also seen that the mouse phagocytes and yeast 
cells did not inactivate the guinea pig complement during 
the incubation period. 
The in vitro technique for quantitating rates of phago-
cytosis and cytopepsis was found to be reproducible when 
Candida guilliermondi cells labeled with P-32 were used as 
labeled particles. The following sections present further 
evidence for the reliability of the technique and include 
studies conducted employing P-32 labeled Histoplasma 
capsulatum, a chronic infectious disease agent, as the 
labeled particle. 
Co Elution rate of P-320 Experimental work during the 
course of this investigation had shown that the yeast phase 
cells of H. capsulatum can be labeled by employing metabolic 
incorporation techniques. The results of Hill (1958) had 
been reproduced, that is, maximum incorporation of P~32 into 
the cells occurred when the cells were grown in liquid medium 
containing between 10 and 20 microcuries of P-32 per mI. The 
specific activity was found to be 900-2000 counts per minute 
per 106 organisms. The isotope appeared to be firmly bound 
since the radioactivity of the supernatant from the yeast 
cell washings was equal to the background count after 4 re-
peated washings. The washed cells were resuspended in 
Earle's BSS after the glucose solution incubation and an 
aliquot containing known activity was transferred to a 50 ml 
79 
glass stoppered flask containing 20 ml of Earle's ESS. At 
various time intervals an aliquot was removed and centrifuged 
at high speed. A sample of the supernatant fluid from the 
centrifuged specimen was transferred to a counting planchet 
and air-dried. The P-32 did not elute from the labeled yeast 
phase lie capsulatum to any significant extent during the 
period of the experiment with the numbers of labeled cells 
employed. 
D~ Effect of Earle's BSS. Peritoneal phagocytes ob-
tained from normal and immunized mice were tested for their 
ability to phagocytize and digest P-32 labeled He capsulatum 
yeast phase cells in the presence of Earle's BSS alone. The 
results are shown in Figure 70 It is seen that phagocytosis 
of the labeled cells by phagocytes from normal or immunized 
mice proceeds at the same rate as evidenced by a decrease in 
the activity of the supernatant fluido Maximum phagocytosis 
occurs at 8 hours after which time the curves remain constant. 
The interpretation assigned is that little digestion of the 
labeled particles is occurringo Microscopic examination of 
cover slip preparations of phagocytes from the same phagocyte 
suspensions revealed that these cells appeared to be dis-
integrating gradually from 16 hours to the termination of 
the experiment at 48 hours. In contrast, microscopic examina-
tion of cells which were suspended in Earle's ESS containing 
20 per cent rabbit serum (heated or non-heated) revealed 
minimal morphological changes during the same period. There-
fore, it appears that some protein is necessary in order that 
the phagocytes maintain their normal morphological character-
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Figure 7. Effect of Earle's BSS on in vitro phagocytosis 
and cytopepsis of P-32 labeled H. capsulatum yeast phase cells 
by peritoneal phagocytes from normal and immunized mice. 
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istics for the time period employed in experiments such as 
those described here. 
The bottom curve seen in Figure 7 represents the P-32 
elution rate from labeled Ho capsulatumo It is seen that 
P-32 does not elute from the organisms during the time of 
the experiment and does not contribute significantly to 
the radioactivity of the supernatant fluid. 
Eo Effect of normal serum. Serum was obtained from 
rabbits in the manner previously described. Serologic assay 
of the serum for complement, properdin, and specific anti-
body for lio capsulatum revealed that the serum contained 
60-100 units per ml of whole complement, 4-8 units per ml 
of properdin, and no complement fixing antibody for H. 
capsulatum. 
Peritoneal phagocytes obtained from normal and immunized 
mice were allowed to attach to the bottom of the reaction 
flasks. After attachment, the normal rabbit serum was 
added to Earle's BSS to a final concentration of 20 per cento 
The final complement and properdin concentrations were cal-
culated to be 12 units per ml and 0.8 - 1.6 units per ml 
respectively. The P-32 labeled yeast phase cells were added, 
and the supernatant fluid was sampled periodically for radio~ 
activity determinations as previously described. It is seen 
in Figure $ that phagocytosis of the labeled particles pro-
ceeds at the same rate whether the phagocytes are from normal 
or immunized mice. fllaximum phagocytosis occurs at 4 hours 
after which time digestion proceeds as evidenced by an 
increase in the radioactivity of the supernatant fluid. It 
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Figure $. Effect of normal rabbit serum on phagocytosis 
and cytopepsis of P-32 labeled yeast phase H. capsulatum cells 
by peritoneal phagocytes from normal and immunized mice. 
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Figure 9. Effect of heated normal rabbit serum on 
phagocytosis and cytopepsis of P-32 labeled yeast phase ti-
capsulatum cells by peritoneal phagocytes from normal and 
immunized mice. 
at a more rapid rate in the "immune" phagocyte preparation 
than in the normal preparation o This difference in digestive 
rates if significantly increased with each increment of time 
and is most pronounced at the termination of the experiment. 
As a control, normal rabbit serum was heated at 56°C 
for 30 minutes, and the same amounts were used as employed 
with the unheated serum o The results are shown in Figure 90 
Again, the phagocytic rates of the normal and "immune" 
phagocytes are not significantly different when compared 
with each other; maximum phagocytosis occurs at 4 hours after 
which time digestion occurs. It is seen that differences 
in digestive rates are not as obvious as in the case of the 
rates in non-heated normal rabbit serum (Figure 8). In 
addition the magnitude of phagocytosis is less than in the 
presence of non-heated serum; for example, there is a de-
crease in supernatant radioactivity of 390 counts per minute 
in 4 hours compared to a decrease of 630 counts per minute 
in 4 hours for the unheated serumo These results suggest that 
a heat-labile factor(s) is necessary for optimal phagocytic 
rates by either normal or "immune" phagocytes. In addition 
a heat-labile component appears to be necessary for the in-
creased enhancement of the digestive rates of "immune" 
phagocytes as compared to the normal phagocyteso 
Fo Effect of serum from immunized rabbits. Serum from 
rabbits immunized against yeast phase lie capsulatum cells 
was serologically assayed for whole complement, properdin 
and specific antibody contento The results showed that the 
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Figure 10 0 Effect of serum from immunized rabbits on 
phagocytosis and cytopepsis of P-32 labeled yeast phase li. 
capsulatum cells by peritoneal phagocytes from normal and 
immunized mice. 
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4-8 units per ml, and the complement fixing antibody titer 
was 1:80. The antibody titer was determined by complement 
fixation test employing a cell-free extract of lio capsulatum 
as antigen (Hill, 1958). 
Peritoneal phagocytes were obtained from normal and 
immunized mice and allowed to attach to the bottom of 50 
ml glass-stoppered flasks in the presence of 20 ml of Earle's 
BSS. At the end of the attachment period, the "immune" 
serum was added to a final concentration of 20 per cent. 
The P-32 labeled lie capsulatum cells were added, and the super-
natant fluid was sampled as previously described. The experi-
mental results are shown in Figure 10. The results indicate 
that phagocytosis of the P-32 labeled organisms by either 
normal or "immune" phagocytes occurs at the same rate. 
Maximum phagocytosis by the normal phagocytes occurred at 4 
hours while the "immune" phagocytes reached a maximum at 2 
hours. This indicates that the ffimmune" phagocytes begin 
to digest the labeled material at a rate which is equal to 
the ingestion rate, whereas the normal phagocytes have an 
ingestive rate much greater than the digestive rate until 
the fourth hour is reached. Evidence to support the above 
observations is gained from analysis of the digestion curves. 
It is seen that digestion of the labeled organisms by the 
"immune u phagocytes occurs faster as evidenced by the sig-
nificant differences in the amounts of P-32 released back to 
the supernatant fluid. 
When the "immune" serum was heated at 56°C for 30 
minutes, to rid the serum of heat-labile components (C' and 
properdin) but not antibody, and tested for effects on 
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Figure 11. Effect of heated serum from immunized rabbits 
on phagocytosis and cytopepsis of P-32 labeled yeast phase H. 
capsulatum cells by peritoneal phagocytes from normal and 
immunized mice. 
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phagocytic and cytopeptic activities of phagocytes from 
normal and immunized mice, a different picture was obtained 
as shown in Figure 11. Phagocytic and digestive activities 
of phagocytes (normal or "immune lt ) are not significantly 
different. Further, it is seen that phagocytosis is slower 
and of lesser magnitude than in the case of the unheated 
"immune" serum experiment. In fact, the curves are not 
significantly different from those plotted with data obtained 
when heated normal serum was used as a variable (Figure 9). 
As in the case of normal serum, a heat-labile component(s) 
appears to be necessary for enhanced digestion rates by 
"immune" phagocytes when compared to the digestion rates of 
the normal phagocyteso In addition a heat-labile component(s) 
appears to enhance the phagocytic rates of both the normal 
and "immune" phagocytes. 
G. Effect of 2 per cent gelatin. In order to further 
clarify the observations seen in the experiment with heated 
'~immunefl serum, that is, that heated "immune" serum (anti-
body) behaves similarly to heated normal serum, an experiment 
was conducted employing 5 per cent gelatin solution as a 
variable. The results are shown in Figure 12. It is seen 
that phagocytosis rates of the normal and "immune" phagocytes 
are not significantly different when compared to each other. 
Very little digestion appears to occur in this menstruum. 
The curves appear similar to that seen with Earle's BSS alone; 
however, a trend toward increased phagocytic rate appears 
when compared to the rate seen in Earle's DSS alone. This 
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Figure 12. Effect of 5 per cent gelatin solution on 
phagocytosis and cytopepsis of P-32 labeled yeast phase 
H. capsulatum cells by peritoneal phagocytes from normal 
and immunized mice. 
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to the phagocytic rates in heated normal or heated "immune" 
serum. Thus, it appears that non-specific "stickiness" of 
latin acts similarly to serum, and that antibody alone does 
not affect the phagocytic rateso 
H. Effect of properdin. In order to determine which 
heat-labile component, that is, complement or properdin, is 
necessary for increased phagocytic and digestive rates by 
normal and "immune" phagocytes, the following experiment was 
conducted. Purified human properdin was added to a final 
concentration of 8 units per ml of Earle's BSS. rrhe P-32 
labeled cells were added and the supernatant fluid sampled 
as reported in the section on materials and methods. It is 
seen in Figure 13 that phagocytosis of the labeled particles 
by normal and "immune" phagocytes does not significantly 
differ, but a trend toward significance occurs in the digestion 
rates. The "immune" phagocytes appear to be slightly more 
active in digestion of the yeast phase cells in this men-
struum. The phagocytic rate appears to be similar with that 
obtained in Earle's BSS alone. This may be explained by the 
fact that the protein content of the added properdin was in 
the microgram range. The final protein content was cal-
culated to be 8 ug per ml; therefore, for all purposes the 
menstruum can be considered similar to Earle's BSS alone~ It 
should be noted that this small amount of protein did cause 
a trend toward enhanced digestion rates by the "immune" 
phagocytes over that seen with the normal phagocytes. 
I~ Effect of zymosan absorbed serao Normal rabbit serum 
was absorbed with zymosan to remove endogenous properdin. 
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Figure 13. Effect of purified human properdin on 
phagocytosis and cytopepsis of P-32 labeled yeast phase He 
capsulatum cells by peritoneal phagocytes from normal and 
immunized mice. 
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The process did not decrease the whole Ct titer appreciably, 
but lowered the properdin content to undetectable levels. This 
RP was used to test the effects of Ct on phagocytic and di-
gestive rates of phagocytes from normal and immunized mice. 
The results are shown in Figure 14. It is seen that the 
phagocytic rates of the normal or "immune" phagocytes are not 
significantly different. In both cases the maximum point is 
reached at 4 hours. However, a significant difference in 
digestion rates is seen which is pronounced at 48 hours. 
This situation is similar to the observed when normal serum 
(complement and properdin) was the menstruum (Figure 8). When 
purified human properdin was added to the normal RP to a 
final concentration of 8 units per ml with respect to the 
total volume of the medium, no significant changes in the 
phagocytic or digestive rate curves occur (Figure 15) when 
compared to the curves in Figure 8. The "immune" phagocytes 
digested the labeled particles significantly faster whether 
in c t alone (RP) or RP plus properdin. The small increase 
in digestive rates observed when properdin alone was tested 
(Figure 13) did not appear to be an additive factor or else 
the increment of increase was so small that it could not be 
detected in this system. 
When zymosan absorbed "immune" serum was employed as a 
variable (C t plus antibody), the same significant increase in 
overall phagocytic rates by both normal and immune phagocytes 
was observed (compare Figure 16 with Figure 10). It appears 
that the lack of properdin does not influence the phagocytic 
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Figure 14. Effect of zymosan-absorbed normal rabbit 
serum on phagocytosis and cytopepsis of P-32 labeled yeast 
phase H. capsulatum cells by peritoneal phagocytes from normal 
and immunized mice. 
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Figure 15. Effect of zymosan absorbed normal rabbit 
serum with added purified human properdin on phagocytosis 
and cytopepsis of P-32 labeled yeast phase H. capsulatum 
cells by peritoneal phagocytes from normal and immunized 
mice. 
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Figure 16. Effect of zymosan absorbed serum from im-
munized rabbits on phagocytosis and cytopepsis of P-32 
labeled yeast phase lie capsulatum cells by peritoneal 
phagocytes from normal and immunized mice. 
I 
96 
magnitude of phagocytosis appeared to approach that observed 
when "immune" serum alone was used as menstruum (compare 
Figure 17 with Figure 10). It is seen from Figure 17 that 
the digestion rates of the "immune" phagocytes significantly 
exceeds that of the normal phagocytes. 
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Figure 170 Effect of zymosan absorbed serum from im-
munized rabbits with added purified human properdin on 
phagocytosis and cytopepsis of P-32 labeled yeast phase Ho 
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Figure 18. Transformation of experimental data to show 
similarity of curves describing phagocytosis obtained by 
isotope technique to that obtained by Ward and Enders (1933) 
using microscopic technique. 
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DISCUSSION 
In order to conduct an investigation of the properdin 
system in host resistance, large amounts of properdin solu-
tions were necessary. Several methods for isolation and 
purification of properdin from serum were attempted. These 
included ammonium sulfate fractionation, continuous curtain 
electrophoresis and whole yeast cell adsorption techniques. 
The ammonium sulfate and electrophoresis procedures were un-
successful. The whole yeast cell adsorption-elution technique 
proved somewhat successful in that properdin solutions of low 
activity were obtained. 
The cold ethanol fractionation procedure had certain 
advantages over the zymosan or whole yeast cell adsorption-
elution procedures. For example, (1) the ethanol procedure 
was completed in one day in contrast to five days required 
for adsorption-elution techniques; (2) solutions with signifi-
cantly greater increases in properdin activity per unit 
volume were obtained by this procedure; and (3) the divalent 
cation and C' component cofactor requirements were eliminated~ 
The partially purified bovine properdin (PPP) obtained 
by cold ethanol fractionation procedures contained considerable 
amounts of extraneous protein as compared to the purified pro-
perdin solutions of Pillemer (1956), i.e., the 2000-fold 
purified product of Pillemer's contained 0.5 ug protein nitrogen 
per unit of properdin while the PPP contained 94 ug of protein 
nitrogen per unit of properdin. 
Large quantities of properdin solutions with high activity 
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per unit volume were necessary for the x-irradiation exper-
iments. The high cost of zymosan prohibited any large 
scale isolation and purification operations; in addition 
products of variable activity were obtained due to variations 
in the different zymosan preparations usedo Under these con-
ditions the PPP solutions were considered adequate for the 
x-irradiation experiments; however, the highly purified pro-
perdin solutions were used in the experiments concerned with 
the in vitro quantitation of phagocytic and cytopeptic rates 
of phagocytes~ 
It is of interest to note that the purification step 
achieved by the inadvertent discovery of the insolubility of 
the properdin containing fraction at DoC was apparently made 
possible by the prior concentration steps. The possible re-
lation of "cryogenic" proteins (Lerner and Greenberg, 1946; 
Lerner and Watson, 1947; Lerner, Barnum and Watson, 1947) to 
the partially purified properdin, which acted similarly to 
described cryogenic globulin, remains to be determinedo 
It has been reported by Ross (1956) that properdin 
levels in rats and mice decrease to undetectable levels fol-
lowing whole body x-irradiationo Linder (1957) reported that 
the properdin levels of 500 r x-irradiated rats falls to 52 
per cent of normal on the third post-irradiation day and 
reaches a minimum of 34 per cent of normal by the eighth 
post-irradiation dayo The properdin level begins to rise and 
reaches 60 per cent of normal on the thirteenth post-irradiation 
dayo It was observed in the present investigation that 
properdin levels of 720 r x-irradiated rats fell rapidly and 
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reached undetectable levels between the fifth and seventh 
post-irradiation days. Furthermore, the properdin levels of 
500 r x-irradiated mice rapidly decreased to 10 per cent of 
normal levels by the fifth post-irradiation day and remained 
undetectable until all animals died on the fifteenth post-
irradiation day. 
If properdin has therapeutic value for whole body x-
irradiated animals, it seemed apparent that treatment should 
be given at a time when the host endogenous levels are at a 
minimum. In all the experiments conducted during this in-
vestigation, the time of administration of exogenous properdin 
was varied in order to include the post-irradiation time during 
which some endogenous properdin is still present (first post-
irradiation day) to when undetectable levels are found (fifth 
to seventh post-irradiation days). It was found that pro-
perdin did not afford any protection to the whole body x-
irradiated animals in doses as high as 600 units given intra-
peritoneally for mice and 1000 units by this route for ratso 
It was observed, however, that time of administration of 
exogenous properdin appears to be an important factor. Trends 
toward delayed mortality were observed to occur if treatment 
was initiated early following exposure to whole body x-
irradiation. In all cases, treatment on the seventh post-
irradiation day accelerated the death rate considerably as 
compared to the controls. This observation was also reported 
by Ross (1956). 
It had been very difficult to obtain properdin solutions 
of high activity per unit volume. Consequently, intravenous 
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injections of properdin of high activity could not be completed 
without introducing large fluid volumeso The choice of the 
intraperitoneal route of injection was made on the assumption 
that the properdin could be absorbed by the animal in doses 
greater than could be administered intravenously without 
causing physiological stress o It is of interest to note 
that in the bactericidal tests conducted with the sera of x-
irradiated rats, no bactericidal activity was measurable 
when the properdin levels of the animals were undetectableo 
Perhaps the failure of properdin to protect the animals 
against the bacteremia that follows whole body x-irradiation 
might be explained on the assumption that sufficient levels 
of systemic properdin were not obtainedo However, in vitro 
studies by Wardlaw and Pillemer (1956) showed that bacteri-
cidal activity of the properdin system occurred with a system 
containing as little as 0 0 01 units of properdino However, 
extrapolation of in vitro observations to in vivo predictions 
must be guardedo Wardlaw and Pillemer also reported that con-
centrations of properdin above 10 units was inhibitory in the 
in vitro bactericidal process. Possibly a minimum of proper-
din would give maximal in vivo protection. In an initial 
experiment in this laboratory, use of properdin of low 
activity (1 unit/ml) yielded 60 per cent 30 day mortality 
among 500 r x-irradiated mice compared to 100 per cent 
mortality of the controls in 15 days. However, attempts to 
confirm this observation have been uniformly negative. 
The negative results obtained when cell-free splenic 
extracts were tested as a therapeutic agent for animals exposed 
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to whole body ionizing radiation might be explained on the 
following basis. The cell-free spleen extract preparation 
used was similar to but different than that of Ellinger 
(1956, 1957), and the induced x-irradiation mortality was 
higher and more rapid with both guinea pigs and mice than in 
Ellinger's experiments. Irradiated animals died within 10 
days whereas in Ellinger's experiments significant differences 
in mortality rates of spleen-treated animals and their saline 
controls were not evident prior to the fifteenth day after 
irradiation. Other deviations from Ellinger's technique 
were reconstitution of lyopilized suspensions to yield in-
jectable material equivalent to 4 spleens rather than 5, the 
injection of this material for 3 or 4 days after irradiation 
rather than for 5 days, the use of repeated freezing and 
thawing of spleen cell suspensions to obtain cell-free extracts 
and the use of ether anesthesia to sacrifice the animals from 
which spleen extracts were prepared. Finally, the intra-
peritoneal rather than intramuscular route was employed for 
injection of mice although not guinea pigs. It is possible 
that the difference in preparation and administration of the 
cell-free extract as well as the method and time of storage 
may have been destructive to the "humoral spleen factor(s)" 
and/or that the higher dosage of irradiation was sufficient 
to mask the effects of the factor(s) is present. Under 
the experimental conditions employed protective humoral 
factors could not be shown to exist in cell-free mouse spleen 
extracts. These results suggest that strict adherence to 
Ellinger's technique and methods is critical. 
104 
No protection to the x-irradiated animals was observed 
as a result of cell-free splenic extract treatment; there-
fore, properdin content correlation studies were not carried 
out. 
Since in vivo experiments could not elucidate the role 
of the properdin system in host resistance, it was decided 
that in vitro experiments be conducted in order to determine 
what effects properdin and other humoral factors had on the 
activities of phagocytes. The effects of humoral factors 
on phagocytic and cytopeptic activities of phagocytes were 
studied by employing a slight modification of the isotope 
technique of Hill (1958). The reliability of the technique 
and the results obtained by this method are discussed in the 
following section. 
In the majority of the reported in vitro experiments 
concerned with phagocytosis, the authors have employed histo-
chemical or manometric techniqueso The use of radioactive 
substances have had their main application in in vivo 
phagocytic studies (Gyi and Marcus, 1957; Kabisch, 1957) 
The use of radioactive labeled substances for in vitro 
phagocytosis studies (Hill, 1958) enables the investigator to 
quantitate the results in a manner that is less laborious 
than microscopic techniqueso Furthermore, the fate of the 
particle within the phagocyte can be quantitated in the same 
isolated systemo As shown in Figure 5, the cover slip 
preparations were radioactively inversely related to the super-
natant fluid. On examination of the stained cover slip 
preparations, it was observed as time progressed that the 
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ingested yeast cells showed various degrees of destruction 
as evidenced by loss of basophilic staining characteristics 
and by actual cell disruption. 
The maximum digestion of the ~. guilliermondi was seen 
by direct microscopy to occur within 4 hourso It was shown 
in Figure 5 that the radioactive counts of the cover slip 
preparations begin to decrease at that time. A working 
hypothesis to explain this phenomenon was that digestion of 
the P-32 labeled Candida caused a release of the isotope to 
the supernatant fluid. Evidence to support this contention 
was gained from the fact that the radioactivity of the fluid 
began to rise during the same increment of time. The fact 
that after 8 hours the supernatant fluid increased and the 
cover slip preparation activity decreased suggests that the 
phagocytes themselves are not appreciably labeledo The cor-
relation study between the radioactive counts and micro-
scopic examination indicated that phagocytosis and cytopepsis 
occurred in the in vitro system. 
In the medium described it was shawn that essentially 
no difference in phagocytic rates occurred at guinea pig 
complement concentrations of 133 or 66 units per ml of buffero 
These C' unit concentrations corresponded to 25 and 12.5 per 
cent serum concentrations respectively. It was observed 
that C' in the above concentrations did not lose any appreciable 
activity when incubated at 370 C for 24 hours~ However, the 
205 per cent serum concentration corresponding to 16 unit0 
per ml of buffer showed a 50 per cent loss of C' activity in 
the same time perioda This observation is in agreement with 
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Kabat and Mayer (1948) who stated "ooothat loss of complement 
activity which occurs during incubation (at 37°C) is more 
marked in higher dilutionso" The mouse phagocytes and yeast 
cells were not anticomplementary in the concentrations used; 
however, previous experiments had shown that c. guilliermondi 
cells in concentrations of 108 or greater per ml of whole 
guinea pig serum inactivated the complement activity within 
60 minutes at 370 C. Subsequent experiments were conducted 
with yeast cell concentrations of approximately 5 x 105 cells 
per ml of buffer, a concentration which was shown to be with-
out effect on C' titer. 
Evidence for the validity of the in vitro technique for 
quantitating rates of phagocytosis and cytopepsis by phagocytes 
was further substantiated by P-32 elution studies. No elution 
studies had been conducted because it was felt that the 
elution rate, if any, would be constant for the labeled yeast 
phase cells in the presence of either normal or "immune" 
phagocytes. However, the experimental work had shown that 
the elution rate of P-32 from labeled cells was not extensive 
during the time of the experiment; thus, leakage from the 
intact cells was a very small factor in contributing to the 
supernatant radioactivity. Therefore, any increase in P-32 
activity in the supernatant fluid must have come from damaged 
and/or digested labeled yeast phase cells, which helped sub-
stantiate the original assumption made for digestion quantita-
tion by this in vitro technique o 
With respect to phagocytosis, one can use similar serum 
variables employed by Ward and Enders (1933), set up the 
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experiment by using this radioactive isotope procedure, plot 
the reciprocal of the counts per minute per ml versus time, 
and obtain curves which are very similar to that obtained by 
Ward and Enders (1933). Such an example is sho'WIl in Figure 
18. The radio-isotope technique had additional value in that 
it was less laborious and more objective o For example, no 
prolonged microscopic examination of preparations was necessary, 
and a means of determining digestion rates in the same system 
was available. 
A working hypothesis that phagocytes from immunized 
animals were endowed with an increased capacity to ingest 
and digest specific material in the absence of any humoral 
factor had been studied. In these experiments the constants 
were (1) peritoneal phagocytes from normal and immunized 
mice, (2) Earle's BSS, (3) P-32 labeled yeast phase lio 
capsulatum cells, and (4) the oscillation rates and incubation 
temperature. The variables were (1) normal serum (e' and 
properdin), (2) heated normal serum, (3) "immune" serum (e', 
properdin and antibody), (4) heated "immune" serum (antibody), 
(5) Zymosan absorbed normal serum (C'), (6) zymosan absorbed 
"immune" serum (C' and antibody), (7) 5 per cent gelatin, 
and ($) purified human properdin. 
From the results obtained by this technique, antibody 
appeared to play little or no role in enhancing phagocytic or 
digestive rates by peritoneal phagocytes from either normal 
or "immune" mice. In every instance where C' was present a 
significant increase in phagocytic rates by both normal and 
"immune" phagocytes was observed. Furthermore, the presence 
108 
of Cf also caused a significant increase in digestion rates 
of the "immune" phagocytes as compared to the normal phagocytes. 
This increased digestive activity was destroyed by heating 
the serum. Therefore, it may be deduced that the phagocytosis 
and digestion promoting factor(s) could be C' or other heat-
labile substances. Properdin showed slight digestion promoting 
activity as well as slight ingestion promoting activity. 
Considerable evidence that thermostable as well as thermolabile 
components are necessary for phagocytosis has been accumulated 
(Cowie and Chapin, 1907; Dean, 1907; Egger, 190$; Ward and 
Enders, 1933; Nelson and Lebrun, 1956). In the experiments 
reported here, antibody appeared to play little or no signifi-
cant role in phagocytosis enhancement. The results suggested 
that a heat-labile component resembling complement and/or 
properdin was responsible for the enhanced phagocytic rates 
by both normal and "immune" phagocytes when a chronic infectious 
disease agent such as H. capsulatum was used as the labeled 
particle. In addition, the heat-labile component(s) appeared 
to endow the "immune" phagocytes with increased digestion 
capacity as compared to the normal phagocytes. The situation 
could be different in the case of an acute disease agent. 
Earlier workers employed acute disease agents in their ex-
perimental work and one must guard against extrapolation of 
data obtained with one type of disease agent to other situa-
tions. It is of interest to note the work of Tullis and 
Surge nor (1956) who studied plasma and serum proteins in an 
attempt to isolate and identify the factors responsible for 
phagocytosis acceleration. They grouped all protein factors 
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that stimulate natural non-immune phagocytos under the 
term of phagocytosis promoting factors {PPfJ. These factors 
were found to be heat-labile, closely associated with comple-
ment and clotting components of plasma, and were suggested 
to act solely on the leucocyteso Perhaps these same factors 
were operative in the series of experiments reported herein. 
SUMMARY 
10 Under carefully controlled conditions bovine serum pro-
perdin was isolated and obtained in a partially purified 
state. The euglobulin was recovered in the serum fraction 
which was insoluble at pH 6.9, -5°C and at an ethanol 
concentration of 20 per cent vivo 
2. Partially purified bovine properdin and purified human 
properdin were employed as therapeutic agents against 
the effects of ionizing radiation in whole body x-
irradiated mice and rats. No protection was observed 
when the solutions were administered intraperitoneally or 
intravenously; however, there appeared to be a relation-
ship between delayed mortality and post-irradiation time 
of injection. 
30 Post-irradiation administration of cell-free mouse 
splenic extract to whole body x-irradiated mice 
(intraperitoneally) and guinea pigs (intramuscularly) 
did not result in protection against post-irradiation 
death. The treated animals died at an accelerated rate 
when compared to the controls. 
4. Candida guilliermondi cells labeled with P-32 were used 
in an in vitro system for quantitating phagocytosis 
and cytopepsis rates by mouse peritoneal phagocyteso 
In this system the optimal concentration of guinea pig 
serum was determined to be 12.5 per cent (66 C' units 
per ml buffer). Complement was not significantly 
inactivated at 37°C for 24 hours in serum concentrations of 
III 
25 and 1205 per cent, but a loss of 50 per cent activity 
occurred when a serum concentration of 2.5 per cent was 
employed() 
50 Yeast phase Histoplasma capsulatum cells labeled with P-32 
were used in a series of experiments to study the effects 
of humoral factors on the in vitro ingestive and digestive 
activities of peritoneal phagocytes obtained from nor-
mal and immunized mice o Among humoral factors studied 
by this technique were complement, properdin and ant 
bodyo In all cases, a heat-labile component (complement 
and/or properdin) not only enhanced phagocytic rates by 
normal and "irmnune" phagocytes, but caused a significant 
enhancement of the digestive activities of the "immune" 
cells as compared to the normal phagocyteso Specific anti-
body did not appear to play any significant role in 
phagocytosis or cytopeps activit s of normal or "immune" 
phagocytes when a chronic disease agent, fiG capsulatum, 
was used as the P-32 labeled organismo 
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ABSTRACT 
Under carefully controlled conditions, bovine serum pro-
perdin was isolated and partially purified by employing cold 
ethanol fractionation procedures o The euglobulin was recovered 
in the serum fraction which was insoluble at pH 6.9, -50 C and 
at a final ethanol concentration of 20 per cent v/v. 
The partially purified bovine properdin and purified human 
properdin were employed as therapeutic agents against the 
effects of ionizing radiation in whole body x-irradiated mice 
and rats. No protection was observed when the solutions were 
administered intraperitoneally or intravenously; however, 
there appeared to be a relationship between delayed mortality 
and post-irradiation time of injection. 
Under the experimental conditions employed, post-
irradiation administration of cell-free mouse splenic ex-
tract to whole body x-irradiated mice (intraperitoneally) 
and guinea pigs (intramuscularly) did not result in protec-
tion against post-irradiation death. The treated animals 
died at an accelerated rate when compared to the controls. 
In vivo experiments could not elucidate the role of the 
properdin system in host resistance; therefore, in vitro tech-
niques for investigating the effect of properdin on phagocytes 
were conducted. Yeast phase Histoplasma capsulatum cells 
labeled with P-32 were used in a series of experiments to 
study the effects of humoral factors on the in vitro inges-
tive and digestive activities of peritoneal phagocytes ob-
tained from normal and immunized mice. Among humoral 
2 
factors studied by this technique were complement, properdin 
and antibody_ In all cases, a heat-labile component (comple-
ment and/or properdin) not only enhanced phagocytic rates 
by normal and "immune" phagocytes, but caused a significant 
enhancement of the digestive activities of the uimmune" cells 
as compared to the normal phagocytes. Specific antibody does 
not appear to play any significant role in phagocytic or 
cytopeptic activities of normal or uimrnune lt phagocytes when 
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RESEARCH PROPOSALS 
10 Complement is always defined in functional terms. A study 
of the effect of various enzymes on complement activity 
might aid in elucidating the constitutive nature of the 
protein complex. 
20 Not all sera can be used for preparation of a serum reagent 
deficient in properdin (RP). What are the factors present 
or absent in sera which are suitable for use? 
3. The role of metallic ions in complement action remains to 
be clarifiedo Employing newer techniques for depleting 
serum of divalent cations, a critical investigation of 
cation requirements of complement in opsonic, bactericidal 
and hemolytic systems should be conducted. 
40 In chronic infectious disease states the host usually gen-
erates humoral antibody which exerts little or no apparent 
effect on acquired resistance. What factors are involved 
in the increased resistance that is apparent? 
50 A common observation in whole body x-irradiated mice (LD50 
range) is an overwhelming bacteremia; in contrast rabbits 
do not exhibit this effect when subjected to the same con-
ditionso Is this a function of depressed activity of phago-
cytosis and/or cytopepsis in the mice and can these effects 
be quantitated? Why do not rabbits develop this bacteremia? 
6. Evidence indicates that complement has opsonizing activit Yo 
To what extent does each complement component contribute 
to the opsonic reaction? 
2 
7. Inactivation of the third component of complement does 
not always occur when complement containing serum is 
mixed with polysaccharides although the polysaccharide-
properdin complex is present. \Vhat factors are involved 
in these apparent exceptions? 
~. The decreased resistance of animals to infection following 
whole body x-irradiation (LD 50 range) is overcome by the 
survivors. ~Vhat factors are involved in the return to 
normality? 
9. Pathogenic bacteria produce substances which contribute 
to the virulence of the organism. To what extent can the 
virulence promoting characteristics of these sUbstances 
be related to interference with humoral or cellular 
resistance mechanisms? 
10. The source of protein exhibiting complement activity is 
unknown. vfuat are the cellular origins involved in the 
synthesis of this protein? 
